Invesco (IVZ) 10-Q 30 Oct 20 2020 Q3 Quarterly report Financial data

Cover Page

Cover Page	9 Months Ended
	Sep. 30, 2020shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-13908
Entity Registrant Name	Invesco Ltd.
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	98-0557567
Entity Address, Address Line One	1555 Peachtree Street, N.E.,
Entity Address, Address Line Two	Suite 1800,
Entity Address, City or Town	Atlanta,
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30309
City Area Code	404
Local Phone Number	892-0896
Title of 12(b) Security	Common stock, $.20 par value
Trading Symbol	IVZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	459,335,113
Entity Central Index Key	0000914208
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 1,066.6	$ 1,049
Unsettled fund receivables	317.5	162.7
Accounts receivable	662.1	855.6
Investments	769.8	829.5
Cash and cash equivalents of CIP	254	652.2
Accounts receivable and other assets of CIP	201.9	172.9
Investments of CIP	7,718.4	7,808
Assets held for policyholders	7,882.5	10,835.6
Prepaid assets	132.2	144
Other assets	436.7	459.6
Property, equipment and software, net	551.1	583.5
Intangible assets, net	7,309.3	7,358.3
Goodwill	8,735.4	8,509.4
Total assets	36,037.5	39,420.3
LIABILITIES
Accrued compensation and benefits	714.9	1,030.7
Accounts payable and accrued expenses	1,810.8	1,904
Debt of CIP	6,526.7	6,234.6
Other liabilities of CIP	520.4	949.6
Policyholder payables	7,882.5	10,835.6
Unsettled fund payables	304.3	154.2
Long-term debt	2,172	2,080.3
Deferred tax liabilities, net	1,527.1	1,529.5
Total liabilities	21,458.7	24,718.5
Commitments and contingencies
TEMPORARY EQUITY
Redeemable noncontrolling interests in consolidated entities	228.2	383.5
Equity attributable to Invesco Ltd.:
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of September 30, 2020 and December 31, 2019)	4,010.5	4,010.5
Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of September 30, 2020 and December 31, 2019)	113.2	113.2
Additional paid-in-capital	7,788.6	7,860.8
Treasury shares	(3,274.9)	(3,452.5)
Retained earnings	5,944.5	5,917.8
Accumulated other comprehensive income/(loss), net of tax	(647.9)	(587.3)
Total equity attributable to Invesco Ltd.	13,934	13,862.5
Equity attributable to nonredeemable noncontrolling interests in consolidated entities	416.6	455.8
Total permanent equity	14,350.6	14,318.3
Total liabilities, temporary and permanent equity	$ 36,037.5	$ 39,420.3

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock par value (in usd per share)	$ 0.2	$ 0.2
Preferred stock liquidation preference (in usd per share)	$ 1,000	$ 1,000
Preferred stock authorized (shares)	4,000,000	4,000,000
Preferred stock issued (shares)	4,000,000	4,000,000
Preferred stock outstanding (shares)	4,000,000	4,000,000
Common stock par value (in usd per share)	$ 0.2	$ 0.2
Common stock authorized (shares)	1,050,000,000	1,050,000,000
Common stock issued (shares)	566,100,000	566,100,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating revenues:
Total operating revenues	$ 1,497.6	$ 1,720.6	$ 4,515.5	$ 4,374.6
Operating expenses:
Third-party distribution, service and advisory	480.8	545.1	1,439.9	1,364.9
Employee compensation	444.5	446	1,321	1,249.2
Marketing	15.6	33.2	62.7	94.6
Property, office and technology	127.5	131.2	386.2	353.3
General and administrative	89.7	104.5	384.9	282.5
Transaction, integration, and restructuring	71	185.5	218.2	536.5
Total operating expenses	1,229.1	1,445.5	3,812.9	3,881
Operating income	268.5	275.1	702.6	493.6
Other income/(expense):
Equity in earnings of unconsolidated affiliates	18.6	19.8	46.7	46.9
Interest and dividend income	2.6	5.9	11.4	14.5
Interest expense	(33.8)	(35)	(104.9)	(101.1)
Other gains and losses, net	31.5	13.8	(15)	69
Other income/(expense) of CIP, net	99.2	37	28.6	127
Income before income taxes	386.6	316.6	669.4	649.9
Income tax provision	(91.9)	(74)	(192.7)	(154.7)
Net income	294.7	242.6	476.7	495.2
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(43.8)	(11.1)	14.6	(45.9)
Dividends declared on preferred shares	(59.2)	(64.4)	(177.6)	(64.4)
Net income attributable to Invesco Ltd.	$ 191.7	$ 167.1	$ 313.7	$ 384.9
Earnings per common share:
- basic (usd per share)	$ 0.42	$ 0.36	$ 0.68	$ 0.89
- diluted (usd per share)	$ 0.41	$ 0.36	$ 0.68	$ 0.89
Investment management fees
Operating revenues:
Total operating revenues	$ 1,096.8	$ 1,257.1	$ 3,302.2	$ 3,252.1
Service and distribution fees
Operating revenues:
Total operating revenues	352.7	385.1	1,051.2	898.5
Performance fees
Operating revenues:
Total operating revenues	0	14.9	8.3	52.4
Other
Operating revenues:
Total operating revenues	$ 48.1	$ 63.5	$ 153.8	$ 171.6

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 294.7	$ 242.6	$ 476.7	$ 495.2
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries	167.4	(133.4)	(61.4)	(71)
Other comprehensive income/(loss), net	0.7	0.5	0.8	1.7
Other comprehensive income/(loss)	168.1	(132.9)	(60.6)	(69.3)
Total comprehensive income/(loss)	462.8	109.7	416.1	425.9
Comprehensive loss/(income) attributable to noncontrolling interests in consolidated entities	(43.8)	(11.1)	14.6	(45.9)
Dividends declared on preferred shares	(59.2)	(64.4)	(177.6)	(64.4)
Comprehensive income/(loss) attributable to Invesco Ltd.	$ 359.8	$ 34.2	$ 253.1	$ 315.6

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net income	$ 476.7	$ 495.2
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Amortization and depreciation	150.3	125.1
Common share-based compensation expense	138.2	158.8
Other (gains)/losses, net	15	(69)
Other (gains)/losses of CIP, net	61.4	(36)
Equity in earnings of unconsolidated affiliates	(46.7)	(46.9)
Distributions from equity method investees	29.9	5.7
Changes in operating assets and liabilities, net of business acquisitions:
(Purchase)/sale of investments by CIP, net	(36.3)	(178)
(Purchase)/sale of investments, net	165.3	98.1
(Increase)/decrease in receivables	2,800.7	520.6
Increase/(decrease) in payables	(3,091.8)	(404.3)
Net cash provided by/(used in) operating activities	662.7	669.3
Investing activities:
Purchase of property, equipment and software	(73.6)	(75.6)
Purchase of investments by CIP	(3,605.5)	(3,033)
Sale of investments by CIP	2,828.3	2,027.5
Purchase of investments	(116.5)	(180.6)
Sale of investments	117.4	98.8
Capital distributions from equity method investees	22.8	64.9
Collateral received/(posted), net	(1.9)	0
Purchase of business, net of cash acquired	0	328.7
Net cash provided by/(used in) investing activities	(829)	(769.3)
Financing activities:
Purchases of treasury shares	(40.7)	(455.4)
Dividends paid - preferred	(177.6)	(64.4)
Dividends paid - common	(285.9)	(388.3)
Third-party capital invested into CIP	133.1	179.7
Third-party capital distributed by CIP	(187.2)	(85.8)
Borrowings of debt by CIP	1,218.8	1,946.6
Repayments of debt by CIP	(773.4)	(1,146.9)
Payment on forward contracts	(190.6)	0
Net borrowings/(repayments) under credit facility	90	(113.9)
Payment of contingent consideration	(16.8)	(11.8)
Net cash provided by/(used in) financing activities	(230.3)	(140.2)
Increase/(decrease) in cash and cash equivalents	(396.6)	(240.2)
Foreign exchange movement on cash and cash equivalents	(5.4)	(15.9)
Foreign exchange movement on cash and cash equivalents of CIP	12.3	(7.6)
Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP	9.1	(7.4)
Cash and cash equivalents, beginning of period	1,701.2	1,805.4
Cash and cash equivalents, end of period	1,320.6	1,534.3
Total cash and cash equivalents per condensed consolidated statement of cash flows	$ 1,320.6	$ 1,534.3

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions	Total	Preferred Shares	Common Shares	Additional Paid-in-Capital	Treasury Shares	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Total Equity Attributable to Invesco Ltd.	Nonredeemable Noncontrolling Interests in Consolidated Entities	Redeemable Noncontrolling Interests in Consolidated Entities Temporary Equity
Beginning balance at Dec. 31, 2018	$ 8,936.2	$ 0	$ 98.1	$ 6,334.8	$ (3,003.6)	$ 5,884.5	$ (735)	$ 8,578.8	$ 357.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	471					449.3		449.3	21.7
Other comprehensive income/(loss)	(69.3)						(69.3)	(69.3)
Change in noncontrolling interests in consolidated entities, net	9.3								9.3
Issuance of shares	5,463.8	4,010.5	15.1	1,438.2				5,463.8
Dividends declared - preferred	(64.4)					(64.4)		(64.4)
Dividends declared - common	(389.4)					(389.4)		(389.4)
Common share-based compensation	158.8			158.8				158.8
Vested common shares	88.7			(107.8)	196.5			88.7
Other common share awards	7.3			(1.2)	8.5			7.3
Purchase of common shares	(650.4)				(650.4)			(650.4)
Ending balance at Sep. 30, 2019	13,961.6	4,010.5	113.2	7,822.8	(3,449)	5,880	(804.3)	13,573.2	388.4
Beginning balance at Dec. 31, 2018										$ 396.2
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										24.2
Change in noncontrolling interests in consolidated entities, net										(22.4)
Ending balance at Sep. 30, 2019										398
Beginning balance at Jun. 30, 2019	14,299.7	4,010.5	113.2	7,810.8	(3,185.2)	5,856.8	(671.4)	13,934.7	365
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	243					231.5		231.5	11.5
Other comprehensive income/(loss)	(132.9)						(132.9)	(132.9)
Change in noncontrolling interests in consolidated entities, net	11.9								11.9
Dividends declared - preferred	(64.4)					(64.4)		(64.4)
Dividends declared - common	(143.9)					(143.9)		(143.9)
Common share-based compensation	49.4			49.4				49.4
Vested common shares	0			(36.3)	36.3			0
Other common share awards	6.7			(1.1)	7.8			6.7
Purchase of common shares	(307.9)				(307.9)			(307.9)
Ending balance at Sep. 30, 2019	13,961.6	4,010.5	113.2	7,822.8	(3,449)	5,880	(804.3)	13,573.2	388.4
Beginning balance at Jun. 30, 2019										396.4
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										(0.4)
Change in noncontrolling interests in consolidated entities, net										2
Ending balance at Sep. 30, 2019										398
Beginning balance at Dec. 31, 2019	14,318.3	4,010.5	113.2	7,860.8	(3,452.5)	5,917.8	(587.3)	13,862.5	455.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	487.9					491.3		491.3	(3.4)
Other comprehensive income/(loss)	(60.6)						(60.6)	(60.6)
Change in noncontrolling interests in consolidated entities, net	(35.8)								(35.8)
Dividends declared - preferred	(177.6)					(177.6)		(177.6)
Dividends declared - common	(287)					(287)		(287)
Common share-based compensation	138.2			138.2				138.2
Vested common shares	0			(200.3)	200.3			0
Other common share awards	7.9			(10.1)	18			7.9
Purchase of common shares	(40.7)				(40.7)			(40.7)
Ending balance at Sep. 30, 2020	14,350.6	4,010.5	113.2	7,788.6	(3,274.9)	5,944.5	(647.9)	13,934	416.6
Beginning balance at Dec. 31, 2019	383.5									383.5
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										(11.2)
Change in noncontrolling interests in consolidated entities, net										(144.1)
Ending balance at Sep. 30, 2020	228.2									228.2
Beginning balance at Jun. 30, 2020	13,967.7	4,010.5	113.2	7,788.4	(3,319.1)	5,825	(816)	13,602	365.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	283.5					250.9		250.9	32.6
Other comprehensive income/(loss)	168.1						168.1	168.1
Change in noncontrolling interests in consolidated entities, net	18.3								18.3
Dividends declared - preferred	(59.2)					(59.2)		(59.2)
Dividends declared - common	(72.2)					(72.2)		(72.2)
Common share-based compensation	43			43				43
Vested common shares	0			(33.3)	33.3			0
Other common share awards	7.2			(9.5)	16.7			7.2
Purchase of common shares	(5.8)				(5.8)			(5.8)
Ending balance at Sep. 30, 2020	14,350.6	$ 4,010.5	$ 113.2	$ 7,788.6	$ (3,274.9)	$ 5,944.5	$ (647.9)	$ 13,934	$ 416.6
Beginning balance at Jun. 30, 2020										202.8
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income										11.2
Change in noncontrolling interests in consolidated entities, net										14.2
Ending balance at Sep. 30, 2020	$ 228.2									$ 228.2

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Changes in Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Stockholders' Equity [Abstract]
Preferred stock dividend declared (in usd per share)	$ 14.75	$ 16.06	$ 44.25	$ 16.06
Common stock dividends declared per share (usd per share)	$ 0.155	$ 0.31	$ 0.62	$ 0.92

Accounting Policies

Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
ACCOUNTING POLICIES	ACCOUNTING POLICIES Corporate Information Invesco Ltd. (Parent) and all of its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of global investment management capabilities. The company operates globally, and its sole business is investment management. Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2019 (annual report or Form 10-K) are not required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these disclosures. Therefore, this Report should be read in conjunction with the company’s annual report. Basis of Accounting and Consolidation The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with rules and regulations of the Securities and Exchange Commission and consolidate the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the financial statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair statement of the financial condition and results of operations for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. Certain reclassifications have been made to prior period amounts to conform to the current period presentation. Use of Estimates The three and nine months ended September 30, 2020 were characterized by heightened uncertainty due to the COVID-19 pandemic which led to a higher level of judgment used in estimates and assumptions made by management. The primary estimates and assumptions made relate to goodwill and intangible impairment, the impact of legal contingencies, certain investments which are carried at fair value, post-employment benefit plan obligations and taxes. Use of available information and application of judgment are inherent in the formation of estimates. Actual results in the future could differ from such estimates, and the differences may be material to the Condensed Consolidated Financial Statements. As of March 31, 2020, we performed interim impairment tests on goodwill and certain indefinite-lived management contract assets due to the decline in our assets under management resulting from COVID-19. The tests performed at that time indicated no impairment. The company determined that interim impairment tests were not necessary in the quarter ended September 30, 2020. The company will perform its annual impairment tests in the fourth quarter as of October 1, 2020. Accounting Pronouncements Recently Adopted Financial Instruments. On January 1, 2020 the company adopted Accounting Standard Update 2016-13, “Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments” (ASU 2016-13) using the modified retrospective approach. ASU 2016-13 amends guidance related to reporting credit losses for financial assets measured at amortized cost and available for sale securities and adds an impairment model that is based on expected losses rather than incurred losses. Under the modified retrospective approach, entities are required to report any effect from adoption as a cumulative effect adjustment to retained earnings at the adoption date. The company has determined that there is no material impact upon adoption of this amendment. Goodwill. On January 1, 2020 the company adopted Accounting Standards Update 2017-04, “Intangibles-Goodwill and Other: Simplifying the Test for Goodwill Impairment” (ASU 2017-04), which revised the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The company has adopted ASU 2017-04 using a prospective approach. In the event a reporting unit’s carrying amount exceeds fair value, the amount of impairment will equal the excess carrying value, not to exceed the total amount of goodwill allocated to the reporting unit. To the extent carrying amount exceeds fair value in a future goodwill impairment test, the amendment will change the amount of impairment expense the company records. Cloud Computing Arrangements. On January 1, 2020 the company adopted Accounting Standards Update 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract” (ASU 2018-15), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The company has adopted ASU 2018-15 using a prospective approach to all implementation costs incurred after adoption. The company has determined that there is no material impact upon adoption of this standard. Pending Accounting Pronouncements None.

Business Combinations

Business Combinations	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
BUSINESS COMBINATIONS	BUSINESS COMBINATIONS On May 24, 2019 , the company acquired OppenheimerFunds, an investment management subsidiary of Massachusetts Mutual Life Insurance Company’s (MassMutual). For details on this transaction, including the consideration transferred and allocation of purchase price, see Note 2, “Business Combinations” in the company’s 2019 10-K. For the nine months ended September 30, 2020, there were $285.8 million in adjustments to the purchase price allocation which primarily related to the OppenheimerFunds acquisition-related matter. As a result of the accounting matter, the company adjusted the initial accounting for the acquisition by recording a liability of an estimated amount of $380.5 million , an adjustment to goodwill of $287.0 million and a deferred tax asset of $93.5 million (for expected future tax benefits) during the first quarter of 2020. See Note 13 , "Commitments and Contingencies" , for additional information. Supplemental Pro Forma Information The following pro forma summary presents consolidated information of the company as if the business combination had occurred on January 1, 2019, the earliest period presented herein. Three months ended September 30, Nine months ended September 30, $ in millions 2019 2019 Operating revenues 1,720.6 5,192.3 Net income 175.3 477.4 The pro forma adjustments include dividends on preferred shares, transaction costs, and adjustments to depreciation and intangible asset amortization expense. Cost savings or operating synergies expected to result from the acquisition are not included in the pro forma results. These pro forma results are not indicative of the actual results of operations that would have been achieved nor are they indicative of future results of operations. The changes in the carrying amount of goodwill from December 31, 2019 to September 30, 2020 are primarily due to the OppenheimerFunds acquisition. $ in millions Net Book Value January 1, 2020 8,509.4 Purchase price adjustments 285.8 Foreign exchange (59.8 ) September 30, 2020 8,735.4 Transaction and integration costs related to the OppenheimerFunds acquisition included within the Transaction, integration, and restructuring line item on the Condensed Consolidated Statements of Income were $45.1 million and $165.5 million , for the three and nine months ended September 30, 2020 .

Fair Value Of Assets And Liabil

Fair Value Of Assets And Liabilities	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE OF ASSETS AND LIABILITIES	FAIR VALUE OF ASSETS AND LIABILITIES The fair value of financial instruments are presented in the below summary table. The fair value of financial instruments held by CIP is presented in Note 14 , "Consolidated Investment Products" . See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. September 30, 2020 December 31, 2019 $ in millions Fair Value Fair Value Cash and cash equivalents 1,066.6 1,049.0 Equity investments 341.5 432.5 Foreign time deposits (1) 29.7 32.0 Assets held for policyholders 7,882.5 10,835.6 Policyholder payables (1) (7,882.5 ) (10,835.6 ) Contingent consideration liability (27.0 ) (60.2 ) ____________ (1) These financial instruments are not recorded on the balance sheet at fair value on a recurring basis. See the most recently filed Form 10-K for additional information about the carrying and fair values of these financial instruments. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities. The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 , respectively: As of September 30, 2020 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 630.6 630.6 Investments (1) : Equity investments: Seed money 153.2 153.2 Investments related to deferred compensation plans 178.9 178.9 Other equity securities 9.4 9.4 Assets held for policyholders 7,882.5 7,882.5 Total 8,854.6 8,854.6 — — Liabilities: Contingent consideration liability (27.0 ) (27.0 ) Total (27.0 ) — — (27.0 ) As of December 31, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 620.9 620.9 — — Investments (1) : Equity investments: Seed money 235.5 235.5 — — Investments related to deferred compensation plans 192.4 192.4 — — Other equity securities 4.6 4.6 — — Assets held for policyholders 10,835.6 10,835.6 — — Total 11,889.0 11,889.0 — — Liabilities: Contingent consideration liability (60.2 ) — — (60.2 ) Total (60.2 ) — — (60.2 ) ____________ (1) Foreign time deposits of $29.7 million ( December 31, 2019 : $32.0 million ) are excluded from this table. Equity method and other investments of $388.3 million and $10.3 million , respectively, ( December 31, 2019 : $350.8 million and $14.2 million , respectively) are also excluded from this table. These investments are not measured at fair value, in accordance with applicable accounting standards. The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities during the three and nine months ended September 30, 2020 and September 30, 2019 , which are valued using significant unobservable inputs: Contingent Consideration Liability $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Beginning balance (29.3 ) (60.2 ) Revision to purchase price allocation — 5.5 Net unrealized gains and losses included in other gains and losses, net (1) (0.5 ) 10.9 Disposition/settlements 2.8 16.8 Ending balance (27.0 ) (27.0 ) Contingent Consideration Liability $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Beginning balance (49.8 ) (40.9 ) Purchases/acquisitions — (15.5 ) Net unrealized gains and losses included in other gains and losses, net (1) (3.2 ) (4.2 ) Disposition/settlements 3.1 10.7 Ending balance (49.9 ) (49.9 ) _______________ (1) These unrealized gains and losses are attributable to balances still held at the respective period ends. Total Return Swaps In addition to holding equity investments, the company has a total return swap (TRS) to economically hedge certain deferred compensation liabilities. The notional value of the total return swap at September 30, 2020 was $252.2 million . During the three and nine months ended September 30, 2020 , market valuation gains of $12.8 million and $11.5 million , respectively were recognized in other gains and losses, net. Contingent Consideration Liability Contingent consideration liabilities represent expected future obligations of the company, are recorded at fair value as of the date of acquisition using a discounted cash flow model and are categorized within level 3 of the valuation hierarchy. Changes in fair value of the company’s contingent consideration liabilities are recorded in other gains and losses, net in the period incurred. An increase in forecasted AUM levels or projected revenue and a decrease in the discount rate would increase the fair value of the company’s contingent consideration liabilities while a decrease in forecasted AUM or projected revenue and an increase in the discount rate would decrease the liabilities. The contingent consideration liability related to the investment management contracts acquired from Deutsche Bank was valued at $9.3 million as of September 30, 2020 . Inputs used in the model to determine the liability related to the pre-existing contingent consideration arrangement, which currently assumes no growth rates in forecasted AUM. In connection with the OppenheimerFunds acquisition (see Note 2 , "Business Combinations" ), Invesco acquired a contingent consideration liability related to a historical OppenheimerFunds transaction valued at $10.7 million as of September 30, 2020 . As of September 30, 2020 , inputs used to determine the liability related to these arrangements assumed no growth rate in management fees and a discount rate of 10.7% . In 2019, the company made other digital wealth acquisitions, which has resulted in a contingent consideration liability of $7.0 million as of September 30, 2020

Investments

Investments	9 Months Ended
	Sep. 30, 2020
Investments [Abstract]
INVESTMENTS	INVESTMENTS The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 14 , "Consolidated Investment Products" . $ in millions September 30, 2020 December 31, 2019 Equity investments: Seed money 153.2 235.5 Investments related to deferred compensation plans 178.9 192.4 Other equity securities 9.4 4.6 Equity method investments 388.3 350.8 Foreign time deposits 29.7 32.0 Other 10.3 14.2 Total investments 769.8 829.5 Equity investments The unrealized gains and losses for the three and nine months ended September 30, 2020 , that relate to equity investments still held at September 30, 2020 , were a $19.9 million net gain , and $18.3 million net loss ( three and nine months ended September 30, 2019 : $0.7 million net gain and $41.1 million net gain ).

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
LONG-TERM DEBT	LONG-TERM DEBT The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 14 , "Consolidated Investment Products" . September 30, 2020 December 31, 2019 $ in millions Carrying Value (2) Fair Value Carrying Value (2) Fair Value $1.5 billion floating rate credit facility expiring August 11, 2022 90.0 90.0 — — Unsecured Senior Notes (1) : $600 million 3.125% - due November 30, 2022 598.6 633.4 598.1 617.5 $600 million 4.000% - due January 30, 2024 596.5 659.1 595.8 639.2 $500 million 3.750% - due January 15, 2026 496.6 565.3 496.1 533.0 $400 million 5.375% - due November 30, 2043 390.3 507.9 390.3 491.8 Long-term debt 2,172.0 2,455.7 2,080.3 2,281.5 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts. The company maintains approximately $11.3 million in letters of credit from a variety of banks. The letters of credit are generally one -year automatically-renewable facilities and are maintained for various commercial reasons.

Share Capital

Share Capital	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
SHARE CAPITAL	SHARE CAPITAL The preferred shares issued in connection with the acquisition of OppenheimerFunds have a $0.20 par value, liquidation preference of $1,000 per share and fixed cash dividend rate of 5.90% per annum, payable quarterly on a non-cumulative basis. Shares of preferred stock are not redeemable prior to the 21 st anniversary of their original issue date of May 24, 2019. The number of preferred shares issued and outstanding is represented in the table below: As of in millions September 30, 2020 December 31, 2019 Preferred shares issued (1) 4.0 4.0 Preferred shares outstanding (1) 4.0 4.0 __________ (1) Preferred shares are held by MassMutual and are subject to a lock-up period of five years , which disallows the sale of preferred shares by MassMutual during the five-year period beginning on the original issue date of May 24, 2019. The number of common shares and common share equivalents issued are represented in the table below: As of in millions September 30, 2020 December 31, 2019 Common shares issued 566.1 566.1 Less: Treasury shares for which dividend and voting rights do not apply (106.8 ) (112.8 ) Common shares outstanding 459.3 453.3 In 2019, the company entered into three forward contracts to purchase its common shares. The details of the forward contracts as of September 30, 2020 and December 31, 2019 , are as follows: in millions, except strike and forward prices September 30, 2020 Common Shares Purchased Initial Strike Price Forward Price Hedge Completion Date Value of Total Treasury Shares Recorded Settlement Date Total Liability Recorded $200 million - entered on May 13, 2019 9.8 $ 20.51 $ 12.00 05/30/2019 $ 198.7 01/04/2021 $ (116.9 ) $200 million - entered on July 2, 2019 10.0 $ 20.00 $ 12.00 07/30/2019 $ 193.7 04/01/2021 $ (118.9 ) $100 million - entered on August 27, 2019 6.0 $ 16.59 $ 12.00 09/27/2019 $ 102.6 04/01/2021 $ (72.9 ) 25.8 $ 495.0 $ (308.7 ) in millions, except strike and forward prices December 31, 2019 Common Shares Purchased Initial Strike Price Forward Price Hedge Completion Date Value of Total Treasury Shares Recorded Settlement Date Total Liability Recorded $200 million - entered on May 13, 2019 9.8 $ 20.51 $ 20.51 05/30/2019 $ 198.7 01/04/2021 $ (199.1 ) $200 million - entered on July 2, 2019 10.0 $ 20.00 $ 20.00 07/30/2019 $ 193.7 04/01/2021 $ (195.3 ) $100 million - entered on August 27, 2019 6.0 $ 16.59 $ 16.59 09/27/2019 $ 102.6 04/01/2021 $ (102.1 ) 25.8 $ 495.0 $ (496.5 ) During the first quarter of 2020, the company amended its forward contracts resulting in a reduced forward price of $12.00 . The company applied $190.6 million of collateral already paid against the forward payable which reduced the amount the company will be required to pay at the time of settlement. The forward liability is recorded in accounts payable and accrued expenses on the Condensed Consolidated Balance Sheet. The net collateral paid balance of $39.7 million at September 30, 2020 ( December 31, 2019 : $37.8 million

Other Comprehensive Income_(Los

Other Comprehensive Income/(Loss)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
OTHER COMPREHENSIVE INCOME/(LOSS)	OTHER COMPREHENSIVE INCOME/(LOSS) The components of accumulated other comprehensive income/(loss) were as follows: For the three months ended September 30, 2020 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries 167.4 — — — 167.4 Other comprehensive income, net — 0.7 — — 0.7 Other comprehensive income/(loss), net of tax 167.4 0.7 — — 168.1 Beginning balance (690.8 ) (125.9 ) 0.1 0.6 (816.0 ) Other comprehensive income/(loss), net of tax 167.4 0.7 — — 168.1 Ending balance (523.4 ) (125.2 ) 0.1 0.6 (647.9 ) For the nine months ended September 30, 2020 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (61.4 ) — — — (61.4 ) Other comprehensive income, net — 0.9 — (0.1 ) 0.8 Other comprehensive income/(loss), net of tax (61.4 ) 0.9 — (0.1 ) (60.6 ) Beginning balance (462.0 ) (126.1 ) 0.1 0.7 (587.3 ) Other comprehensive income/(loss), net of tax (61.4 ) 0.9 — (0.1 ) (60.6 ) Ending balance (523.4 ) (125.2 ) 0.1 0.6 (647.9 ) For the three months ended September 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (133.4 ) — — — (133.4 ) Other comprehensive income, net — 0.5 — — 0.5 Other comprehensive income/(loss), net of tax (133.4 ) 0.5 — — (132.9 ) Beginning balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) Other comprehensive income/(loss), net of tax (133.4 ) 0.5 — — (132.9 ) Ending balance (688.6 ) (116.4 ) 0.1 0.6 (804.3 ) For the nine months ended September 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (71.0 ) — — — (71.0 ) Other comprehensive income, net — 1.3 0.1 0.3 1.7 Other comprehensive income/(loss), net of tax (71.0 ) 1.3 0.1 0.3 (69.3 ) Beginning balance (617.6 ) (117.7 ) — 0.3 (735.0 ) Other comprehensive income/(loss), net of tax (71.0 ) 1.3 0.1 0.3 (69.3 ) Ending balance (688.6 ) (116.4 ) 0.1 0.6 (804.3 ) Net Investment Hedge The company designated certain intercompany debt as a non-derivative net investment hedging instrument against foreign currency exposure related to its net investment in foreign operations. At September 30, 2020 and December 31, 2019 , £130 million ( $168.5 million and $172.1 million , respectively) of intercompany debt was designated as a net investment hedge. For the three and nine months ended September 30, 2020 , the company recognized foreign currency losses and gains of $5.8 million and $3.6 million , respectively ( three and nine months ended September 30, 2019 : gains of $5.3 million and $5.4 million , respectively) resulting from the net investment hedge within currency translation differences on investments in foreign subsidiaries in Other comprehensive income.

Revenue

Revenue	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE The geographic disaggregation of revenue for the three and nine months ended September 30, 2020 and 2019 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. For the three months ended September 30, $ in millions 2020 2019 Americas 1,118.2 1,286.0 UK 148.6 191.4 EMEA ex UK (Europe, Middle East, and Africa) 158.2 169.2 Asia 72.6 74.0 Total operating revenues 1,497.6 1,720.6 For the nine months ended September 30, $ in millions 2020 2019 Americas 3,356.2 3,037.5 UK 465.3 611.9 EMEA ex UK (Europe, Middle East, and Africa) 468.3 507.5 Asia 225.7 217.7 Total operating revenues 4,515.5 4,374.6 The opening and closing balances of deferred carried interest liabilities for the nine months ended September 30, 2020 were $45.8 million and $58.0 million , respectively ( December 31, 2019 : $61.3 million and $45.8 million , respectively). During the nine months ended September 30, 2020 , no performance fee revenue was recognized that had been included in the deferred carried interest liability balance at the beginning of the period ( September 30, 2019 : $6.8 million

Common Share-Based Compensation

Common Share-Based Compensation	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
COMMON SHARE-BASED COMPENSATION	COMMON SHARE-BASED COMPENSATION The company recognized total expenses of $138.2 million and $158.8 million related to equity-settled common share-based payment transactions in the nine months ended September 30, 2020 and 2019 , respectively. Movements on common share awards during the periods ended September 30 , are detailed below: For the nine months ended For the nine months ended September 30, 2019 millions of common shares, except fair values Time- Vested Performance- Vested Weighted Average Grant Date Fair Value ($) Time- Vested Performance- Vested Unvested at the beginning of period 18.7 1.1 21.94 12.5 0.9 Granted during the period (1) 8.1 0.9 14.08 15.4 0.6 Forfeited during the period (0.3 ) — 21.08 (0.5 ) — Vested and distributed during the period (7.7 ) (0.2 ) 24.54 (8.1 ) (0.1 ) Unvested at the end of the period 18.8 1.8 19.42 19.3 1.4 (1) With respect to the time-vested awards, the nine months ended September 30, 2019 includes 6.2 million restricted shares as employment inducement awards in connection with completed acquisitions. The total fair value of common shares that vested during the nine months ended September 30, 2020 was $109.6 million ( nine months ended September 30, 2019 : $161.0 million ). The weighted average grant date fair value of the common share awards that were granted during the nine months ended September 30, 2020 was $14.08 ( nine months ended September 30, 2019 : $14.47 ). At September 30, 2020 , there was $276.0 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be recognized over a weighted average period of 2.41 years.

Operating Leases

Operating Leases	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
OPERATING LEASES	OPERATING LEASES The company leases office space in almost all its locations of business, data centers and certain equipment under non-cancelable operating leases. The operating leases have a weighted-average remaining lease term of 5.86 years and generally include one or more options to renew, with renewal terms that can extend the lease term from 1 to 10 years. Certain lease arrangements include an option to terminate the lease if a notification is provided to the landlord within 1 to 8.5 years prior to the end of the lease term. The company has sole discretion in exercising lease renewal and termination options. The lease terms used in the company’s lease measurements do not include renewal options as they are not reasonably certain to be exercised as of the date of this report. The company elected to combine lease and non-lease components in calculating the lease liability and right-of-use asset for operating leases. Variable lease payments are determined based on the terms and conditions outlined in the lease contracts and are primarily determined in relation to the extent of the company’s usage of the right-of use asset or the nature and extent of services received from the lessor. As of September 30, 2020 , the right-of-use asset of $307.4 million was included within Other assets, and the lease liability of $335.0 million was included within Accounts payable and accrued expenses, on the Condensed Consolidated Balance Sheets. The components of lease expense for the three and nine months ended September 30, 2020 were as follows: $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Operating lease cost 23.2 65.0 Variable lease cost 5.7 16.9 Less: sublease income (0.5 ) (1.5 ) Total lease expense 28.4 80.4 $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating lease cost 19.9 49.7 Variable lease cost 6.8 19.5 Less: sublease income (0.2 ) (0.4 ) Total lease expense 26.5 68.8 Supplemental cash flow information related to leases for the three and nine months ended September 30, 2020 was as follows: $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Operating cash flows from operating leases included in the measurement of lease liabilities 23.9 69.3 Right-of-use assets obtained in exchange for new operating lease liabilities 6.8 35.1 $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating cash flows from operating leases included in the measurement of lease liabilities 20.9 54.1 Right-of-use assets obtained in exchange for new operating lease liabilities 13.5 161.9 In determining the discount rate, the company considered the interest rate yield for specific interest rate environments and the company’s credit spread at the inception of the lease. The weighted-average discount rate for the operating lease liability for the nine months ended September 30, 2020 was 3.37% . As of September 30, 2020 the maturities of the company’s lease liabilities (primarily related to real estate leases) were as follows: $ in millions Year Ending December 31, Lease Liabilities 2020 (excluding the nine months ended September 30, 2020) 23.4 2021 78.9 2022 69.1 2023 55.9 2024 39.6 Thereafter 103.0 Total lease payments 369.9 Less: interest (34.9 ) Present value of lease liabilities 335.0 Excluded from the table above is an additional operating lease for the company’s new Atlanta headquarters that was entered into during third quarter of 2019, but has not yet commenced. The expected lease obligations are approximately $232.5 million which will be paid over an expected lease term of 15 years . This operating lease will commence in fiscal year 2022 and will replace the company’s existing lease for the current headquarters.

Taxation

Taxation	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
TAXATION	TAXATION On March 27, 2020, the United States enacted the Coronavirus Aid, Relief, and Economic Security (CARES) Act as a result of the Coronavirus pandemic, which contains among other things, numerous income tax provisions. Some of these tax provisions are expected to be effective retroactively for years ending before the date of enactment. The company has evaluated the current legislation and at this time, does not anticipate the CARES Act to have a material impact on its financial statements. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: $ in millions Gross Unrecognized Income Tax Benefits Balance at December 31, 2019 69.9 Additions for tax positions related to the current year 2.0 Additions for tax positions related to prior years 0.9 Other reductions for tax positions related to prior years (0.8 ) Reductions for statute closings (9.3 ) Balance at September 30, 2020 62.7 At September 30, 2020 , the total amount of gross unrecognized tax benefits was $62.7 million as compared to the December 31, 2019 total of $69.9 million . During the nine months ended September 30, 2020 the company recognized a $9.3 million tax benefit that resulted primarily from the expiration of a state statute of limitations for a previously recorded position. The remainder of the movement is comprised of additions to existing positions net of other settlements and reductions. Of the total amount of gross unrecognized tax benefits, $48.8 million (net of tax benefits in other jurisdictions and the federal benefit of state taxes) represents the amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate in future periods. As a result of potential legislative changes, settlements with taxing authorities and the expiration of statutes of limitations for certain jurisdictions, it is reasonably possible that the company's gross unrecognized tax benefits balance may change within the next twelve months by a range of $6.0 million to $12.0 million .

Earnings Per Common Share

Earnings Per Common Share	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The calculation of earnings per common share is as follows: For the three months ended September 30, For the nine months ended September 30, in millions, except per share data 2020 2019 2020 2019 Net income attributable to Invesco Ltd. 191.7 167.1 313.7 384.9 Invesco Ltd: Weighted average common shares outstanding - basic 461.1 462.8 459.0 432.3 Dilutive effect of non-participating common share-based awards 2.4 4.1 3.0 2.3 Weighted average common shares outstanding - diluted 463.5 466.9 462.0 434.6 Earnings per common share: -basic $0.42 $0.36 $0.68 $0.89 -diluted $0.41 $0.36 $0.68 $0.89 See Note 9 , "Common Share-Based Compensation" , for a summary of common share awards outstanding under the company’s common share-based compensation programs. These programs could result in the issuance of common shares from time to time that would affect the measurement of basic and diluted earnings per common share. There were 0.3 million common shares of performance-vested awards excluded from the computation of diluted earnings per common share during the three and nine months ended September 30 , 2020 due to their inclusion being anti-dilutive ( three and nine months ended September 30, 2019 : 0.7 million ). There were no common shares of time-vested awards excluded from the computation of diluted earnings per common share during three and nine months ended September 30 , 2020 ( three and nine months ended September 30, 2019 : none

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments and contingencies may arise in the ordinary course of business. Off Balance Sheet Commitments The company has committed to co-invest in certain investment products which may be called in future periods. At September 30, 2020 , the company’s undrawn capital commitments were $385.1 million ( December 31, 2019 : $357.0 million ). The Parent and various company subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote. The company entered into several forward contracts to purchase its common shares. See Note 6 , "Share Capital" , for details of these forward contracts and the related liability outstanding at September 30, 2020 . Pursuant to an agreement entered into at the consummation of the acquisition of OppenheimerFunds, MassMutual, as the holder of seed capital investments in certain funds and accounts included in the acquisition, has the right to redeem its seed capital investments in accordance with an agreed upon schedule. In the event MassMutual exercises its redemption rights and the applicable fund or account is unable to meet such redemption (for example, due to illiquid investments or the need to maintain a level of investment in the fund), the company would be required to fund such redemption to MassMutual and seek reimbursement from the applicable fund or account at a later time when the fund or account is able to fulfill a redemption request. At September 30, 2020 , the total amount of seed capital subject to this agreement is approximately $322.7 million . Legal Contingencies The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other parties who may share in any ultimate liability. In assessing the impact that a legal or regulatory matter will have on the company, management evaluates the need for an accrual on a case-by-case basis. If the likelihood of a loss is deemed probable and is reasonably estimable, the estimated loss is accrued. If the likelihood of a loss is assessed as less than probable, or an amount or range of loss cannot be reasonably estimated, a loss is not accrued. In management’s opinion, adequate accrual has been made as of September 30, 2020 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount. Management is of the opinion that the ultimate resolution of such claims will not materially affect the company’s business, financial position, results of operation or liquidity. Furthermore, in management’s opinion, it is not possible to estimate a range of reasonably possible losses with respect to other litigation contingencies. The investment management industry also is subject to extensive levels of ongoing regulatory oversight and examination. In the United States, United Kingdom, and other jurisdictions in which the company operates, governmental authorities regularly make inquiries, hold investigations and administer market conduct examinations with respect to the company’s compliance with applicable laws and regulations. Additional lawsuits or regulatory enforcement actions arising out of these inquiries may in the future be filed against the company and related entities and individuals in the United States, United Kingdom, and other jurisdictions in which the company and its affiliates operate. Any material loss of investor and/or client confidence as a result of such inquiries and/or litigation could result in a significant decline in AUM, which would have an adverse effect on the company’s future financial results and its ability to grow its business. OppenheimerFunds acquisition-related matter In the fourth quarter 2019, the company identified an accounting matter which has required that the historical financial statements for certain funds identified below be restated. This matter also will result in remediation costs, all or at least some portion of which the company expects to bear. Uncertainties remain as of the date of this report regarding the nature, scope and amounts of such costs, as well as the degree to which the company will ultimately be financially responsible for bearing such costs. Set forth below is a more detailed description of this matter, based on information available as of the date of this report. This matter pertains to the following four Master Limited Partnership (MLP) funds: (1) the Invesco Oppenheimer Steelpath MLP Income Fund; (2) the Invesco Oppenheimer Steelpath MLP Select 40 Fund; (3) the Invesco Oppenheimer Steelpath MLP Alpha Fund; and (4) the Invesco Oppenheimer Steelpath MLP Alpha Plus Fund (each a Fund and together the Funds). The company acquired sponsorship and management of the Funds on May 24, 2019 as part of its acquisition of OppenheimerFunds. The Funds invest substantially all their assets in entities that are MLPs for tax purposes. As a result, the Funds are taxable entities subject to Subchapter C of the Internal Revenue Code of 1986, as amended (the Tax Code). This is unusual, as most mutual funds are instead subject to Subchapter M of the Tax Code (and, in general, operate as flow through vehicles for tax purposes thereunder). Because of their tax status, the Funds have tax attributes, including deferred tax assets and deferred tax liabilities, and must make assessments as to the amount of deferred tax assets that may be realizable in accordance with ASC 740 Income Taxes (ASC 740). In preparing their financial statements for the fiscal year ended November 30, 2019, questions arose as to whether the Funds’ previously issued financial statements for certain years failed to include appropriate valuation allowances against the Funds’ deferred tax assets in accordance with ASC 740. Following a regulatory consultation on these matters that concluded after the company filed its 2019 Annual Report on Form 10-K, the Funds determined that certain previously issued financial statements had to be restated (which the Funds have now done), and the Funds have recorded incorrect Net Asset Values (NAVs) for periods dating back to 2015. Remediating these matters has, will or may produce the following costs: • Costs of processing the restated historical financial statements, and related costs of communicating with present and former Fund shareholders; • Costs of reimbursing shareholders for transactions in Fund shares made at incorrect NAVs and for certain fees paid by the Funds based thereon; and • Certain additional costs in connection with these matters. As stated above, uncertainties remain regarding the nature, scope and amount of these costs. Furthermore, there is uncertainty as to the degree to which the company will become ultimately responsible to absorb some or all such costs. The sources of such uncertainties include, among other things, the following: • The process and method for determining such remediation is subject to various factors that are not yet certain and information that is not yet readily available. In this regard, a significant amount of the investors in the Funds are held in omnibus accounts where the company does not at this time have access to the level of data necessary to determine the appropriate remediation. • The company and/or the Funds may be entitled to seek reimbursement for certain of such costs under applicable insurance policies (subject to the terms of such policies, including applicable deductibles and policy limits). • The company may be entitled to seek indemnification for certain of such costs from MassMutual under the OppenheimerFunds acquisition agreement (subject to the terms of such indemnification, including the specified deductible and limit). During first quarter of 2020, the company recorded an estimated liability of $387.8 million for both pre and post-acquisition activity related to the matter. For pre-acquisition activity, the company recorded an adjustment to the initial acquisition accounting for a liability of an estimated amount of $380.5 million in accordance with ASC 805 Business Combinations and a corresponding adjustment was recorded to goodwill and deferred tax assets. (See Note 2 , "Business Combinations" , for additional information.) This estimate excludes any amounts that may be recovered through seller indemnifications and insurance recoveries. The estimate also excludes other costs related to the matter, such as the costs of remediation or the costs of communicating with fund shareholders. Additionally, the company recognized a liability of an estimated amount of $7.3 million for activity after the acquisition date, which was recorded in earnings. Both amounts reflect management’s best estimate based on its current understanding of the relevant facts and circumstances as of September 30, 2020 . The measurement period for this transaction closed during the three months ended June 30, 2020; therefore, any further adjustments to the estimate, including any recoveries from insurance or indemnifications, will be recorded through earnings. Fund Rebalancing Matter During the second quarter of 2020, the company discovered and corrected an error with respect to two funds: the Invesco Equally-Weighted S&P 500 Fund and Invesco V.I. Equally-Weighted S&P 500 Fund (the Funds). The Funds are passive funds that are managed to track the S&P 500 Equal Weight Index (the Index). In March 2020, due to volatility in the equity markets, S&P Dow Jones Indices communicated the decision to delay, and ultimately to separate, the rebalancing dates for its indices and noted some indices would be rebalanced in April and others in June. The company noted this delay but not the separation of rebalance dates and omitted rebalancing the Funds on April 24, 2020 when S&P rebalanced the Index. The company discovered this omission and rebalanced the Funds on April 29, 2020. The company has paid the Funds $105.3 million to compensate them for the performance difference that arose from market movements between April 24 and April 29. This amount was recorded as a general and administrative expense during the nine months ended September 30, 2020. The company will seek reimbursement of this loss under applicable insurance coverages (subject to the terms of such policies, including applicable deductibles and policy limits)

Consolidated Investment Product

Consolidated Investment Products (CIP)	9 Months Ended
	Sep. 30, 2020
Consolidated Investment Products [Abstract]
CONSOLIDATED INVESTMENT PRODUCTS (CIP)	CONSOLIDATED INVESTMENT PRODUCTS (CIP) The following table presents the balances related to CIP that are included on the Condensed Consolidated Balance Sheets as well as Invesco’s net interest in the CIP for each period presented. See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. As of $ in millions September 30, 2020 December 31, 2019 Cash and cash equivalents of CIP 254.0 652.2 Accounts receivable and other assets of CIP 201.9 172.9 Investments of CIP 7,718.4 7,808.0 Less: Debt of CIP (6,526.7 ) (6,234.6 ) Less: Other liabilities of CIP (520.4 ) (949.6 ) Less: Retained earnings 0.1 9.5 Less: Accumulated other comprehensive income, net of tax — (9.4 ) Less: Equity attributable to redeemable noncontrolling interests (228.2 ) (383.5 ) Less: Equity attributable to nonredeemable noncontrolling interests (415.9 ) (454.9 ) Invesco’s net interests in CIP 483.2 610.6 The following table reflects the impact of consolidation of investment products into the Condensed Consolidated Statements of Income for the three and nine months ended September 30 , 2020 and 2019 : Three months ended September 30, Nine months ended September 30, $ in millions 2020 2019 2020 2019 Total operating revenues (10.4 ) (8.5 ) (29.8 ) (24.4 ) Total operating expenses 4.4 9.4 22.9 17.6 Operating income (14.8 ) (17.9 ) (52.7 ) (42.0 ) Equity in earnings of unconsolidated affiliates (26.0 ) (9.5 ) 10.8 (8.6 ) Interest and dividend income — (0.7 ) (0.3 ) (3.1 ) Other gains and losses, net (5.0 ) 0.3 8.4 (28.7 ) Interest and dividend income of CIP 76.3 90.4 241.2 261.8 Interest expense of CIP (41.8 ) (58.0 ) (151.2 ) (170.8 ) Other gains/(losses) of CIP, net 64.7 4.6 (61.4 ) 36.0 Income before income taxes 53.4 9.2 (5.2 ) 44.6 Net income 53.4 9.2 (5.2 ) 44.6 Net (income)/loss attributable to noncontrolling interests in consolidated entities (43.8 ) (11.1 ) 14.6 (45.9 ) Net income attributable to Invesco Ltd. 9.6 (1.9 ) 9.4 (1.3 ) Non-consolidated VIEs At September 30, 2020 , the company’s carrying value and maximum risk of loss with respect to variable interest entities (VIEs) in which the company is not the primary beneficiary was $164.9 million ( December 31, 2019 : $188.0 million ). Balance Sheet information - newly consolidated VIEs/VOEs During the nine months ended September 30, 2020 , there were four newly consolidated variable interest entities (VIEs) and no newly consolidated voting rights entities (VOEs) ( September 30, 2019 : there were three newly consolidated VIEs and five newly consolidated VOEs. The table below illustrates the summary balance sheet amounts related to these products before consolidation into the company. The balances below are reflective of the balances existing at the consolidation date after the initial funding of the investments by the company and unrelated third-party investors. The current period activity for the consolidated funds, including the initial funding and subsequent investment of initial cash balances into underlying investments of CIP, is reflected in the company’s Condensed Consolidated Financial Statements. For the nine months ended September 30, 2020 For the nine months ended September 30, 2019 $ in millions VIEs VIEs Cash and cash equivalents of CIP 9.1 9.9 Accounts receivable and other assets of CIP 1.2 3.1 Investments of CIP 114.2 401.9 Total assets 124.5 414.9 Debt of CIP 75.8 188.8 Other liabilities of CIP 37.8 226.1 Total liabilities 113.6 414.9 Total equity 10.9 — Total liabilities and equity 124.5 414.9 Balance Sheet information - deconsolidated VIEs/VOEs During the nine months ended September 30, 2020 , the company determined that it was no longer the primary beneficiary of seven VIEs and no longer held the majority voting interest in eleven VOEs ( September 30, 2019 : the company determined that it was no longer the primary beneficiary of six VIEs and no longer held the majority voting interest in nine VOEs). The amounts deconsolidated from the Condensed Consolidated Balance Sheets are illustrated in the table below. There was no net impact to the Condensed Consolidated Statements of Income for the nine months ended September 30, 2020 and 2019 from the deconsolidation of these investment products. For the nine months ended September 30, 2020 For the nine months ended September 30, 2019 $ in millions VIEs VOEs VIEs VOEs Cash and cash equivalents of CIP 0.4 0.2 7.6 (0.2 ) Accounts receivable and other assets of CIP 2.8 1.1 22.3 0.3 Investments of CIP 216.9 134.1 626.1 37.0 Total assets 220.1 135.4 656.0 37.1 Debt of CIP — — 526.2 — Other liabilities of CIP 2.0 — 22.2 — Total liabilities 2.0 — 548.4 — Total equity 218.1 135.4 107.6 37.1 Total liabilities and equity 220.1 135.4 656.0 37.1 The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of September 30, 2020 and December 31, 2019 : As of September 30, 2020 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 6,616.6 — 6,616.6 — — Bonds 550.3 — 550.3 — — Equity securities 278.0 202.4 75.6 — — Equity and fixed income mutual funds 23.3 0.4 22.9 — — Investments in other private equity funds 250.2 — 7.6 — 242.6 Total assets at fair value 7,718.4 202.8 7,273.0 — 242.6 As of December 31, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 6,504.4 — 6,504.4 — — Bonds 705.9 0.5 705.4 — — Equity securities 275.9 204.4 71.5 — — Equity and fixed income mutual funds 29.8 20.3 9.5 — — Investments in other private equity funds 213.4 — — — 213.4 Real estate investments 78.6 — — 78.6 — Total assets at fair value 7,808.0 225.2 7,290.8 78.6 213.4 The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs: Three months ended September 30, 2020 Nine months ended September 30, 2020 $ in millions Level 3 Assets Level 3 Assets Beginning balance — 78.6 Purchases — — Sales — — Issuances — — Settlements — — Deconsolidation of CIP — (89.4 ) Gains and losses included in the Condensed Consolidated Statements of Income — 10.8 Ending balance — — Three months ended September 30, 2019 Nine months ended September 30, 2019 $ in millions Level 3 Assets Level 3 Assets Beginning balance 14.5 11.8 Purchases 17.2 17.2 Gains and losses included in the Condensed Consolidated Statements of Income 0.3 3.0 Ending balance 32.0 32.0 The collateral assets held by consolidated CLOs are primarily invested in senior secured bank loans, bonds, and equity securities. Bank loan investments of $6,596.8 million , which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans from a variety of industries, including but not limited to the aerospace and defense, broadcasting, technology, utilities, household products, healthcare, oil and gas, and finance industries. Bank loan investments mature at various dates between 2020 and 2029 , pay interest at LIBOR plus a spread of up to 10.0% , and typically range in S&P credit rating categories from BBB down to unrated. Approximately less than 1.03% of the collateral assets were in default as of September 30, 2020 and 2019 . Interest income on bank loans and bonds is recognized based on the unpaid principal balance and stated interest rate of these investments on an accrual basis. At September 30, 2020 , the unpaid principal balance exceeds the fair value of the senior secured bank loans and bonds by approximately $287.8 million ( December 31, 2019 : the unpaid principal balance exceeded the fair value of the senior secured bank loans and bonds by approximately $181.2 million ). These investments are accounted for on a one-month lag based on the availability of fund financial information, which means the third quarter fair value reflects a valuation as of August 31, 2020. CLO investments are valued based on price quotations provided by third-party pricing sources. These third-party sources aggregate indicative price quotations to provide the company with a price for the CLO investments. The company has developed internal controls to review the reasonableness and completeness of these price quotations. If necessary, price quotations are challenged through a third-party pricing challenge process. Notes issued by consolidated CLOs mature at various dates between 2026 and 2033 and have a weighted average maturity of 10.28 years. The notes are issued in various tranches with different risk profiles. The interest rates are generally variable rates based on LIBOR plus a pre-defined spread, which varies from 0.40% for the more senior tranches to 8.07% for the more subordinated tranches. The investors in this debt are not affiliated with the company and have no recourse to the general credit of the company for this debt . Quantitative Information about Level 3 Fair Value Measurement At September 30, 2020 , there were no investments held by consolidated real estate funds that were valued using recent private market transactions. At December 31, 2019, there were $78.6 million of investments held by consolidated real estate funds that were valued using recent private market transactions. The table below summarizes as of September 30, 2020 and December 31, 2019 , the nature of investments that are valued using the NAV as a practical expedient and any related liquidation restrictions or other factors which may impact the ultimate value realized. These investments are valued on a three-month lag based on the availability of fund financial information. September 30, 2020 December 31, 2019 in millions, except term data Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Private equity funds (1) $242.6 $118.2 6.8 years $213.4 $78.3 6.7 years ____________ (1) These investments are not subject to redemption; however, for certain funds, the investors may sell or transfer their interest, which may require approval by the general partner of the underlying funds. (2) These investments are expected to be returned through distributions because of liquidations of the funds’ underlying assets over the weighted average periods indicated.

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTIES	RELATED PARTIES As a result of the OppenheimerFunds acquisition (see Note 2 , "Business Combinations" ), MassMutual has an approximate 16.5% stake in the common stock of the company and owns all of the outstanding $4.0 billion in perpetual, non-cumulative preferred shares. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes representation on Invesco’s board of directors, the company considers MassMutual a related party. Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” Related parties include those defined in the company’s proxy statement. Affiliated balances are illustrated in the tables below: Three months ended September 30, Nine months ended September 30, $ in millions 2020 2019 2020 2019 Affiliated operating revenues: Investment management fees 987.2 1,133.5 2,975.2 2,905.3 Service and distribution fees 338.9 375.6 1,004.8 864.1 Performance fees — 14.1 3.4 37.5 Other 46.4 60.3 149.4 161.2 Total affiliated operating revenues 1,372.5 1,583.5 4,132.8 3,968.1 $ in millions September 30, 2020 December 31, 2019 Affiliated asset balances: Cash and cash equivalents 630.6 620.9 Unsettled fund receivables 266.1 113.6 Accounts receivable 435.4 599.8 Investments 601.9 633.5 Assets held for policyholders 7,882.2 10,835.3 Other assets 22.2 24.5 Total affiliated asset balances 9,838.4 12,827.6 Affiliated liability balances: Accrued compensation and benefits 22.7 65.7 Accounts payable and accrued expenses 80.8 53.8 Unsettled fund payables 273.1 116.6 Total affiliated liability balances 376.6 236.1

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On October 27, 2020 , the company announced a third quarter 2020 dividend of $0.155 per common share, payable on December 2, 2020 , to common shareholders of record at the close of business on November 12, 2020 with an ex-dividend date of November 10, 2020 . On October 27, 2020 the company declared a preferred dividend of $14.75 per preferred share, representing the period from September 1, 2020 through November 30, 2020 . The preferred dividend is payable on December 1, 2020 , to preferred shareholders of record at the close of business on November 16, 2020

Accounting Policies (Policy)

Accounting Policies (Policy)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting and Consolidation	Basis of Accounting and Consolidation
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to the current period presentation.
Use of Estimates	Use of Estimates The three and nine months ended September 30, 2020 were characterized by heightened uncertainty due to the COVID-19 pandemic which led to a higher level of judgment used in estimates and assumptions made by management. The primary estimates and assumptions made relate to goodwill and intangible impairment, the impact of legal contingencies, certain investments which are carried at fair value, post-employment benefit plan obligations and taxes. Use of available information and application of judgment are inherent in the formation of estimates. Actual results in the future could differ from such estimates, and the differences may be material to the Condensed Consolidated Financial Statements.
Goodwill and Indefinite-lived Asset Impairment	As of March 31, 2020, we performed interim impairment tests on goodwill and certain indefinite-lived management contract assets due to the decline in our assets under management resulting from COVID-19. The tests performed at that time indicated no impairment. The company determined that interim impairment tests were not necessary in the quarter ended September 30, 2020.
Accounting Pronouncements Recently Adopted and Pending Accounting Pronouncements	Accounting Pronouncements Recently Adopted Financial Instruments. On January 1, 2020 the company adopted Accounting Standard Update 2016-13, “Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments” (ASU 2016-13) using the modified retrospective approach. ASU 2016-13 amends guidance related to reporting credit losses for financial assets measured at amortized cost and available for sale securities and adds an impairment model that is based on expected losses rather than incurred losses. Under the modified retrospective approach, entities are required to report any effect from adoption as a cumulative effect adjustment to retained earnings at the adoption date. The company has determined that there is no material impact upon adoption of this amendment. Goodwill. On January 1, 2020 the company adopted Accounting Standards Update 2017-04, “Intangibles-Goodwill and Other: Simplifying the Test for Goodwill Impairment” (ASU 2017-04), which revised the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The company has adopted ASU 2017-04 using a prospective approach. In the event a reporting unit’s carrying amount exceeds fair value, the amount of impairment will equal the excess carrying value, not to exceed the total amount of goodwill allocated to the reporting unit. To the extent carrying amount exceeds fair value in a future goodwill impairment test, the amendment will change the amount of impairment expense the company records. Cloud Computing Arrangements. On January 1, 2020 the company adopted Accounting Standards Update 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract” (ASU 2018-15), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The company has adopted ASU 2018-15 using a prospective approach to all implementation costs incurred after adoption. The company has determined that there is no material impact upon adoption of this standard. Pending Accounting Pronouncements None.

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Sep. 30, 2020
Business Combinations [Abstract]
Schedule of Pro Forma Information	The following pro forma summary presents consolidated information of the company as if the business combination had occurred on January 1, 2019, the earliest period presented herein. Three months ended September 30, Nine months ended September 30, $ in millions 2019 2019 Operating revenues 1,720.6 5,192.3 Net income 175.3 477.4
Schedule of Goodwill	The changes in the carrying amount of goodwill from December 31, 2019 to September 30, 2020 are primarily due to the OppenheimerFunds acquisition. $ in millions Net Book Value January 1, 2020 8,509.4 Purchase price adjustments 285.8 Foreign exchange (59.8 ) September 30, 2020 8,735.4

Fair Value Of Assets And Liab_2

Fair Value Of Assets And Liabilities (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value By Balance Sheet Grouping	The fair value of financial instruments are presented in the below summary table. The fair value of financial instruments held by CIP is presented in Note 14 , "Consolidated Investment Products" . See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. September 30, 2020 December 31, 2019 $ in millions Fair Value Fair Value Cash and cash equivalents 1,066.6 1,049.0 Equity investments 341.5 432.5 Foreign time deposits (1) 29.7 32.0 Assets held for policyholders 7,882.5 10,835.6 Policyholder payables (1) (7,882.5 ) (10,835.6 ) Contingent consideration liability (27.0 ) (60.2 ) ____________ (1) These financial instruments are not recorded on the balance sheet at fair value on a recurring basis. See the most recently filed Form 10-K for additional information about the carrying and fair values of these financial instruments. Foreign time deposits are measured at cost plus accrued interest, which approximates fair value, and are accordingly classified as Level 2 securities.
Tri-Level Hierarchy, Carrying Value	The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 , respectively: As of September 30, 2020 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 630.6 630.6 Investments (1) : Equity investments: Seed money 153.2 153.2 Investments related to deferred compensation plans 178.9 178.9 Other equity securities 9.4 9.4 Assets held for policyholders 7,882.5 7,882.5 Total 8,854.6 8,854.6 — — Liabilities: Contingent consideration liability (27.0 ) (27.0 ) Total (27.0 ) — — (27.0 ) As of December 31, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs Significant Unobservable Inputs Assets: Cash equivalents: Money market funds 620.9 620.9 — — Investments (1) : Equity investments: Seed money 235.5 235.5 — — Investments related to deferred compensation plans 192.4 192.4 — — Other equity securities 4.6 4.6 — — Assets held for policyholders 10,835.6 10,835.6 — — Total 11,889.0 11,889.0 — — Liabilities: Contingent consideration liability (60.2 ) — — (60.2 ) Total (60.2 ) — — (60.2 ) ____________ (1) Foreign time deposits of $29.7 million ( December 31, 2019 : $32.0 million ) are excluded from this table. Equity method and other investments of $388.3 million and $10.3 million , respectively, ( December 31, 2019 : $350.8 million and $14.2 million , respectively) are also excluded from this table. These investments are not measured at fair value, in accordance with applicable accounting standards.
Reconciliation of Balance, Fair Value Measurement, Level 3	The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets and liabilities during the three and nine months ended September 30, 2020 and September 30, 2019 , which are valued using significant unobservable inputs: Contingent Consideration Liability $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Beginning balance (29.3 ) (60.2 ) Revision to purchase price allocation — 5.5 Net unrealized gains and losses included in other gains and losses, net (1) (0.5 ) 10.9 Disposition/settlements 2.8 16.8 Ending balance (27.0 ) (27.0 ) Contingent Consideration Liability $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Beginning balance (49.8 ) (40.9 ) Purchases/acquisitions — (15.5 ) Net unrealized gains and losses included in other gains and losses, net (1) (3.2 ) (4.2 ) Disposition/settlements 3.1 10.7 Ending balance (49.9 ) (49.9 ) _______________ (1) These unrealized gains and losses are attributable to balances still held at the respective period ends.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2020
Investments [Abstract]
Marketable securities	The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 14 , "Consolidated Investment Products" . $ in millions September 30, 2020 December 31, 2019 Equity investments: Seed money 153.2 235.5 Investments related to deferred compensation plans 178.9 192.4 Other equity securities 9.4 4.6 Equity method investments 388.3 350.8 Foreign time deposits 29.7 32.0 Other 10.3 14.2 Total investments 769.8 829.5

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule Of Long-Term Debt Instruments	The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 14 , "Consolidated Investment Products" . September 30, 2020 December 31, 2019 $ in millions Carrying Value (2) Fair Value Carrying Value (2) Fair Value $1.5 billion floating rate credit facility expiring August 11, 2022 90.0 90.0 — — Unsecured Senior Notes (1) : $600 million 3.125% - due November 30, 2022 598.6 633.4 598.1 617.5 $600 million 4.000% - due January 30, 2024 596.5 659.1 595.8 639.2 $500 million 3.750% - due January 15, 2026 496.6 565.3 496.1 533.0 $400 million 5.375% - due November 30, 2043 390.3 507.9 390.3 491.8 Long-term debt 2,172.0 2,455.7 2,080.3 2,281.5 ____________ (1) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the indentures. (2) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.

Share Capital (Tables)

Share Capital (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Movements In Shares Issued And Outstanding	The number of preferred shares issued and outstanding is represented in the table below: As of in millions September 30, 2020 December 31, 2019 Preferred shares issued (1) 4.0 4.0 Preferred shares outstanding (1) 4.0 4.0 __________ (1) Preferred shares are held by MassMutual and are subject to a lock-up period of five years , which disallows the sale of preferred shares by MassMutual during the five-year period beginning on the original issue date of May 24, 2019. The number of common shares and common share equivalents issued are represented in the table below: As of in millions September 30, 2020 December 31, 2019 Common shares issued 566.1 566.1 Less: Treasury shares for which dividend and voting rights do not apply (106.8 ) (112.8 ) Common shares outstanding 459.3 453.3
Schedule of Forward Contracts Indexed to Issuer's Equity	The details of the forward contracts as of September 30, 2020 and December 31, 2019 , are as follows: in millions, except strike and forward prices September 30, 2020 Common Shares Purchased Initial Strike Price Forward Price Hedge Completion Date Value of Total Treasury Shares Recorded Settlement Date Total Liability Recorded $200 million - entered on May 13, 2019 9.8 $ 20.51 $ 12.00 05/30/2019 $ 198.7 01/04/2021 $ (116.9 ) $200 million - entered on July 2, 2019 10.0 $ 20.00 $ 12.00 07/30/2019 $ 193.7 04/01/2021 $ (118.9 ) $100 million - entered on August 27, 2019 6.0 $ 16.59 $ 12.00 09/27/2019 $ 102.6 04/01/2021 $ (72.9 ) 25.8 $ 495.0 $ (308.7 ) in millions, except strike and forward prices December 31, 2019 Common Shares Purchased Initial Strike Price Forward Price Hedge Completion Date Value of Total Treasury Shares Recorded Settlement Date Total Liability Recorded $200 million - entered on May 13, 2019 9.8 $ 20.51 $ 20.51 05/30/2019 $ 198.7 01/04/2021 $ (199.1 ) $200 million - entered on July 2, 2019 10.0 $ 20.00 $ 20.00 07/30/2019 $ 193.7 04/01/2021 $ (195.3 ) $100 million - entered on August 27, 2019 6.0 $ 16.59 $ 16.59 09/27/2019 $ 102.6 04/01/2021 $ (102.1 ) 25.8 $ 495.0 $ (496.5 )

Other Comprehensive Income_(L_2

Other Comprehensive Income/(Loss) (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income	The components of accumulated other comprehensive income/(loss) were as follows: For the three months ended September 30, 2020 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries 167.4 — — — 167.4 Other comprehensive income, net — 0.7 — — 0.7 Other comprehensive income/(loss), net of tax 167.4 0.7 — — 168.1 Beginning balance (690.8 ) (125.9 ) 0.1 0.6 (816.0 ) Other comprehensive income/(loss), net of tax 167.4 0.7 — — 168.1 Ending balance (523.4 ) (125.2 ) 0.1 0.6 (647.9 ) For the nine months ended September 30, 2020 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (61.4 ) — — — (61.4 ) Other comprehensive income, net — 0.9 — (0.1 ) 0.8 Other comprehensive income/(loss), net of tax (61.4 ) 0.9 — (0.1 ) (60.6 ) Beginning balance (462.0 ) (126.1 ) 0.1 0.7 (587.3 ) Other comprehensive income/(loss), net of tax (61.4 ) 0.9 — (0.1 ) (60.6 ) Ending balance (523.4 ) (125.2 ) 0.1 0.6 (647.9 ) For the three months ended September 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (133.4 ) — — — (133.4 ) Other comprehensive income, net — 0.5 — — 0.5 Other comprehensive income/(loss), net of tax (133.4 ) 0.5 — — (132.9 ) Beginning balance (555.2 ) (116.9 ) 0.1 0.6 (671.4 ) Other comprehensive income/(loss), net of tax (133.4 ) 0.5 — — (132.9 ) Ending balance (688.6 ) (116.4 ) 0.1 0.6 (804.3 ) For the nine months ended September 30, 2019 $ in millions Foreign currency translation Employee benefit plans Equity method investments Available-for-sale investments Total Other comprehensive income/(loss), net of tax: Currency translation differences on investments in foreign subsidiaries (71.0 ) — — — (71.0 ) Other comprehensive income, net — 1.3 0.1 0.3 1.7 Other comprehensive income/(loss), net of tax (71.0 ) 1.3 0.1 0.3 (69.3 ) Beginning balance (617.6 ) (117.7 ) — 0.3 (735.0 ) Other comprehensive income/(loss), net of tax (71.0 ) 1.3 0.1 0.3 (69.3 ) Ending balance (688.6 ) (116.4 ) 0.1 0.6 (804.3 )

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Geographic disaggregation of revenue	The geographic disaggregation of revenue for the three and nine months ended September 30, 2020 and 2019 are presented below. There are no revenues attributed to the company’s country of domicile, Bermuda. For the three months ended September 30, $ in millions 2020 2019 Americas 1,118.2 1,286.0 UK 148.6 191.4 EMEA ex UK (Europe, Middle East, and Africa) 158.2 169.2 Asia 72.6 74.0 Total operating revenues 1,497.6 1,720.6 For the nine months ended September 30, $ in millions 2020 2019 Americas 3,356.2 3,037.5 UK 465.3 611.9 EMEA ex UK (Europe, Middle East, and Africa) 468.3 507.5 Asia 225.7 217.7 Total operating revenues 4,515.5 4,374.6

Common Share-Based Compensati_2

Common Share-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Movements Of Share Awards	Movements on common share awards during the periods ended September 30 , are detailed below: For the nine months ended For the nine months ended September 30, 2019 millions of common shares, except fair values Time- Vested Performance- Vested Weighted Average Grant Date Fair Value ($) Time- Vested Performance- Vested Unvested at the beginning of period 18.7 1.1 21.94 12.5 0.9 Granted during the period (1) 8.1 0.9 14.08 15.4 0.6 Forfeited during the period (0.3 ) — 21.08 (0.5 ) — Vested and distributed during the period (7.7 ) (0.2 ) 24.54 (8.1 ) (0.1 ) Unvested at the end of the period 18.8 1.8 19.42 19.3 1.4 (1) With respect to the time-vested awards, the nine months ended September 30, 2019 includes 6.2 million restricted shares as employment inducement awards in connection with completed acquisitions.

Operating Leases (Tables)

Operating Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Components of Lease Expense and Supplemental Cash Flow Information Related to Leases	The components of lease expense for the three and nine months ended September 30, 2020 were as follows: $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Operating lease cost 23.2 65.0 Variable lease cost 5.7 16.9 Less: sublease income (0.5 ) (1.5 ) Total lease expense 28.4 80.4 $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating lease cost 19.9 49.7 Variable lease cost 6.8 19.5 Less: sublease income (0.2 ) (0.4 ) Total lease expense 26.5 68.8 Supplemental cash flow information related to leases for the three and nine months ended September 30, 2020 was as follows: $ in millions Three months ended September 30, 2020 Nine months ended September 30, 2020 Operating cash flows from operating leases included in the measurement of lease liabilities 23.9 69.3 Right-of-use assets obtained in exchange for new operating lease liabilities 6.8 35.1 $ in millions Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating cash flows from operating leases included in the measurement of lease liabilities 20.9 54.1 Right-of-use assets obtained in exchange for new operating lease liabilities 13.5 161.9
Maturities of Company's Lease Liabilities	As of September 30, 2020 the maturities of the company’s lease liabilities (primarily related to real estate leases) were as follows: $ in millions Year Ending December 31, Lease Liabilities 2020 (excluding the nine months ended September 30, 2020) 23.4 2021 78.9 2022 69.1 2023 55.9 2024 39.6 Thereafter 103.0 Total lease payments 369.9 Less: interest (34.9 ) Present value of lease liabilities 335.0

Taxation (Tables)

Taxation (Tables)	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Reconciliation of Beginning and Ending Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: $ in millions Gross Unrecognized Income Tax Benefits Balance at December 31, 2019 69.9 Additions for tax positions related to the current year 2.0 Additions for tax positions related to prior years 0.9 Other reductions for tax positions related to prior years (0.8 ) Reductions for statute closings (9.3 ) Balance at September 30, 2020 62.7

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Calculation Of Earnings Per Share	The calculation of earnings per common share is as follows: For the three months ended September 30, For the nine months ended September 30, in millions, except per share data 2020 2019 2020 2019 Net income attributable to Invesco Ltd. 191.7 167.1 313.7 384.9 Invesco Ltd: Weighted average common shares outstanding - basic 461.1 462.8 459.0 432.3 Dilutive effect of non-participating common share-based awards 2.4 4.1 3.0 2.3 Weighted average common shares outstanding - diluted 463.5 466.9 462.0 434.6 Earnings per common share: -basic $0.42 $0.36 $0.68 $0.89 -diluted $0.41 $0.36 $0.68 $0.89

Consolidated Investment Produ_2

Consolidated Investment Products (CIP) (Tables)	9 Months Ended
	Sep. 30, 2020
Consolidated Investment Products [Abstract]
Balances Related To CIP	The following table presents the balances related to CIP that are included on the Condensed Consolidated Balance Sheets as well as Invesco’s net interest in the CIP for each period presented. See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value. As of $ in millions September 30, 2020 December 31, 2019 Cash and cash equivalents of CIP 254.0 652.2 Accounts receivable and other assets of CIP 201.9 172.9 Investments of CIP 7,718.4 7,808.0 Less: Debt of CIP (6,526.7 ) (6,234.6 ) Less: Other liabilities of CIP (520.4 ) (949.6 ) Less: Retained earnings 0.1 9.5 Less: Accumulated other comprehensive income, net of tax — (9.4 ) Less: Equity attributable to redeemable noncontrolling interests (228.2 ) (383.5 ) Less: Equity attributable to nonredeemable noncontrolling interests (415.9 ) (454.9 ) Invesco’s net interests in CIP 483.2 610.6
Condensed Consolidating Statement Of Income Line Items Reflecting Impact Of Consolidation Of Investment Products Into The Condensed Consolidated Statements Of Income	The following table reflects the impact of consolidation of investment products into the Condensed Consolidated Statements of Income for the three and nine months ended September 30 , 2020 and 2019 : Three months ended September 30, Nine months ended September 30, $ in millions 2020 2019 2020 2019 Total operating revenues (10.4 ) (8.5 ) (29.8 ) (24.4 ) Total operating expenses 4.4 9.4 22.9 17.6 Operating income (14.8 ) (17.9 ) (52.7 ) (42.0 ) Equity in earnings of unconsolidated affiliates (26.0 ) (9.5 ) 10.8 (8.6 ) Interest and dividend income — (0.7 ) (0.3 ) (3.1 ) Other gains and losses, net (5.0 ) 0.3 8.4 (28.7 ) Interest and dividend income of CIP 76.3 90.4 241.2 261.8 Interest expense of CIP (41.8 ) (58.0 ) (151.2 ) (170.8 ) Other gains/(losses) of CIP, net 64.7 4.6 (61.4 ) 36.0 Income before income taxes 53.4 9.2 (5.2 ) 44.6 Net income 53.4 9.2 (5.2 ) 44.6 Net (income)/loss attributable to noncontrolling interests in consolidated entities (43.8 ) (11.1 ) 14.6 (45.9 ) Net income attributable to Invesco Ltd. 9.6 (1.9 ) 9.4 (1.3 )
VIE Balance Sheets Consolidated In Period	The table below illustrates the summary balance sheet amounts related to these products before consolidation into the company. The balances below are reflective of the balances existing at the consolidation date after the initial funding of the investments by the company and unrelated third-party investors. The current period activity for the consolidated funds, including the initial funding and subsequent investment of initial cash balances into underlying investments of CIP, is reflected in the company’s Condensed Consolidated Financial Statements. For the nine months ended September 30, 2020 For the nine months ended September 30, 2019 $ in millions VIEs VIEs Cash and cash equivalents of CIP 9.1 9.9 Accounts receivable and other assets of CIP 1.2 3.1 Investments of CIP 114.2 401.9 Total assets 124.5 414.9 Debt of CIP 75.8 188.8 Other liabilities of CIP 37.8 226.1 Total liabilities 113.6 414.9 Total equity 10.9 — Total liabilities and equity 124.5 414.9 no net impact to the Condensed Consolidated Statements of Income for the nine months ended September 30, 2020 and 2019 from the deconsolidation of these investment products. For the nine months ended September 30, 2020 For the nine months ended September 30, 2019 $ in millions VIEs VOEs VIEs VOEs Cash and cash equivalents of CIP 0.4 0.2 7.6 (0.2 ) Accounts receivable and other assets of CIP 2.8 1.1 22.3 0.3 Investments of CIP 216.9 134.1 626.1 37.0 Total assets 220.1 135.4 656.0 37.1 Debt of CIP — — 526.2 — Other liabilities of CIP 2.0 — 22.2 — Total liabilities 2.0 — 548.4 — Total equity 218.1 135.4 107.6 37.1 Total liabilities and equity 220.1 135.4 656.0 37.1
Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products	The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of September 30, 2020 and December 31, 2019 : As of September 30, 2020 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 6,616.6 — 6,616.6 — — Bonds 550.3 — 550.3 — — Equity securities 278.0 202.4 75.6 — — Equity and fixed income mutual funds 23.3 0.4 22.9 — — Investments in other private equity funds 250.2 — 7.6 — 242.6 Total assets at fair value 7,718.4 202.8 7,273.0 — 242.6 As of December 31, 2019 $ in millions Fair Value Measurements Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Investments Measured at NAV as a practical expedient Assets: Bank loans 6,504.4 — 6,504.4 — — Bonds 705.9 0.5 705.4 — — Equity securities 275.9 204.4 71.5 — — Equity and fixed income mutual funds 29.8 20.3 9.5 — — Investments in other private equity funds 213.4 — — — 213.4 Real estate investments 78.6 — — 78.6 — Total assets at fair value 7,808.0 225.2 7,290.8 78.6 213.4
Beginning And Ending Fair Value Measurements For Level 3 Assets And Liabilities	The following tables show a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs: Three months ended September 30, 2020 Nine months ended September 30, 2020 $ in millions Level 3 Assets Level 3 Assets Beginning balance — 78.6 Purchases — — Sales — — Issuances — — Settlements — — Deconsolidation of CIP — (89.4 ) Gains and losses included in the Condensed Consolidated Statements of Income — 10.8 Ending balance — — Three months ended September 30, 2019 Nine months ended September 30, 2019 $ in millions Level 3 Assets Level 3 Assets Beginning balance 14.5 11.8 Purchases 17.2 17.2 Gains and losses included in the Condensed Consolidated Statements of Income 0.3 3.0 Ending balance 32.0 32.0
Fair Value Inputs, Assets and Liabilities, Quantitative Information, Consolidated Investment Products	The table below summarizes as of September 30, 2020 and December 31, 2019 , the nature of investments that are valued using the NAV as a practical expedient and any related liquidation restrictions or other factors which may impact the ultimate value realized. These investments are valued on a three-month lag based on the availability of fund financial information. September 30, 2020 December 31, 2019 in millions, except term data Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Fair Value Total Unfunded Commitments Weighted Average Remaining Term (2) Private equity funds (1) $242.6 $118.2 6.8 years $213.4 $78.3 6.7 years ____________ (1) These investments are not subject to redemption; however, for certain funds, the investors may sell or transfer their interest, which may require approval by the general partner of the underlying funds. (2) These investments are expected to be returned through distributions because of liquidations of the funds’ underlying assets over the weighted average periods indicated.

Related Parties (Tables)

Related Parties (Tables)	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Affiliated balances are illustrated in the tables below: Three months ended September 30, Nine months ended September 30, $ in millions 2020 2019 2020 2019 Affiliated operating revenues: Investment management fees 987.2 1,133.5 2,975.2 2,905.3 Service and distribution fees 338.9 375.6 1,004.8 864.1 Performance fees — 14.1 3.4 37.5 Other 46.4 60.3 149.4 161.2 Total affiliated operating revenues 1,372.5 1,583.5 4,132.8 3,968.1 $ in millions September 30, 2020 December 31, 2019 Affiliated asset balances: Cash and cash equivalents 630.6 620.9 Unsettled fund receivables 266.1 113.6 Accounts receivable 435.4 599.8 Investments 601.9 633.5 Assets held for policyholders 7,882.2 10,835.3 Other assets 22.2 24.5 Total affiliated asset balances 9,838.4 12,827.6 Affiliated liability balances: Accrued compensation and benefits 22.7 65.7 Accounts payable and accrued expenses 80.8 53.8 Unsettled fund payables 273.1 116.6 Total affiliated liability balances 376.6 236.1

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Business Acquisition [Line Items]
Purchase price adjustments				$ 285.8
Transaction, integration, and restructuring	$ 71		$ 185.5	218.2	$ 536.5
OppenheimerFunds
Business Acquisition [Line Items]
Purchase price adjustments		$ 287
Liability adjustment		380.5
Deferred tax asset adjustment		$ 93.5
Transaction, integration, and restructuring	$ 45.1			$ 165.5

Business Combinations - Schedul

Business Combinations - Schedule of Pro Forma Information (Details) - OppenheimerFunds - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Operating revenues	$ 1,720.6	$ 5,192.3
Net income	$ 175.3	$ 477.4

Business Combinations - Sched_2

Business Combinations - Schedule of Changes in Carrying Amounts of Goodwill (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Goodwill [Roll Forward]
Goodwill	$ 8,509.4
Purchase price adjustments	285.8
Foreign exchange	(59.8)
Goodwill	$ 8,735.4

Fair Value Of Assets And Liab_3

Fair Value Of Assets And Liabilities - Fair Value Of Financial Instruments Held By Consolidated Investments (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$ 1,066.6	$ 1,049	$ 1,048.6
Foreign time deposits	29.7	32
Policyholder payables	(7,882.5)	(10,835.6)
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	1,066.6	1,049
Equity investments	341.5	432.5
Foreign time deposits	29.7	32
Assets held for policyholders	7,882.5	10,835.6
Policyholder payables	(7,882.5)	(10,835.6)
Contingent consideration liability	$ (27)	$ (60.2)

Fair Value Of Assets And Liab_4

Fair Value Of Assets And Liabilities - Tri-Level Hierarchy, Carrying Value (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	$ 7,882.5	$ 10,835.6
Total	8,854.6	11,889
Total	(27)	(60.2)
Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	(27)	(60.2)
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	630.6	620.9
Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	153.2	235.5
Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	178.9	192.4
Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	9.4	4.6
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders	7,882.5	10,835.6
Total	8,854.6	11,889
Total	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability		0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	630.6	620.9
Quoted Prices in Active Markets for Identical Assets (Level 1) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	153.2	235.5
Quoted Prices in Active Markets for Identical Assets (Level 1) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	178.9	192.4
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments	9.4	4.6
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders		0
Total	0	0
Total	0	0
Significant Other Observable Inputs (Level 2) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability		0
Significant Other Observable Inputs (Level 2) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds		0
Significant Other Observable Inputs (Level 2) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		0
Significant Other Observable Inputs (Level 2) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		0
Significant Other Observable Inputs (Level 2) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for policyholders		0
Total	0	0
Total	(27)	(60.2)
Significant Unobservable Inputs (Level 3) | Contingent consideration liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability	(27)	(60.2)
Significant Unobservable Inputs (Level 3) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds		0
Significant Unobservable Inputs (Level 3) | Seed money
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		0
Significant Unobservable Inputs (Level 3) | Investments related to deferred compensation plans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		0
Significant Unobservable Inputs (Level 3) | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investments		$ 0

Fair Value Of Assets And Liab_5

Fair Value Of Assets And Liabilities - Narrative (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign time deposits	$ 29.7	$ 29.7	$ 32
Equity method investments	388.3	388.3	350.8
Other investments	10.3	$ 10.3	14.2
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assumed growth rate of Assets under Management (percent)		0.00%
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	2,172	$ 2,172	$ 2,080.3
Total Return Swap | Designated as Hedging Instrument
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative notional amount	252.2	252.2
Market valuation loss recognized	12.8	11.5
Deutche Bank
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability acquired	9.3	9.3
OppenheimerFunds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability acquired	$ 10.7	$ 10.7
OppenheimerFunds | Assumed growth rate | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0	0
OppenheimerFunds | Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Inputs used to determine liability (percent)	0.107	0.107
Other Digital Wealth Acquisitions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability acquired	$ 7	$ 7

Fair Value Of Assets And Liab_6

Fair Value Of Assets And Liabilities - Reconciliation Of Balance, Fair Value Measurement, Level 3 (Details) - Contingent consideration liability - Significant Unobservable Inputs (Level 3) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Liability)	$ (29.3)	$ (49.8)	$ (60.2)	$ (40.9)
Revision to purchase price allocation	0		5.5
Purchases/acquisitions		0		(15.5)
Net unrealized gains and losses included in other gains and losses, net	(0.5)	(3.2)	10.9	(4.2)
Disposition/settlements	2.8	3.1	16.8	10.7
Ending balance (Liability)	$ (27)	$ (49.9)	$ (27)	$ (49.9)

Investments - Details Of Compan

Investments - Details Of Company Investments (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Investment Holdings [Line Items]
Equity method investments	$ 388.3	$ 350.8
Foreign time deposits	29.7	32
Other	10.3	14.2
Total investments	769.8	829.5
Seed money
Investment Holdings [Line Items]
Equity investments	153.2	235.5
Investments related to deferred compensation plans
Investment Holdings [Line Items]
Equity investments	178.9	192.4
Other equity securities
Investment Holdings [Line Items]
Equity investments	$ 9.4	$ 4.6

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Short-term Investments
Debt Securities, Available-for-sale [Line Items]
Net gains (loss)	$ 19.9	$ (18.3)	$ 0.7	$ 41.1

Long-Term Debt - Schedule Of Lo

Long-Term Debt - Schedule Of Long-Term Debt Instruments (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.125%
Debt instrument, face amount	$ 600,000,000
Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.00%
Debt instrument, face amount	$ 600,000,000
Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.75%
Debt instrument, face amount	$ 500,000,000
Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	5.375%
Debt instrument, face amount	$ 400,000,000
$1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Debt instrument, face amount	1,500,000,000
Carrying Value
Debt Instrument [Line Items]
Long-term debt	2,172,000,000	$ 2,080,300,000
Carrying Value | Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Long-term debt	598,600,000	598,100,000
Carrying Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Long-term debt	596,500,000	595,800,000
Carrying Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Long-term debt	496,600,000	496,100,000
Carrying Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Long-term debt	390,300,000	390,300,000
Carrying Value | $1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	90,000,000	0
Fair Value
Debt Instrument [Line Items]
Long-term debt	2,455,700,000	2,281,500,000
Fair Value | Unsecured Senior Notes | $600 million 3.125% - due November 30, 2022
Debt Instrument [Line Items]
Long-term debt	633,400,000	617,500,000
Fair Value | Unsecured Senior Notes | $600 million 4.000% - due January 30, 2024
Debt Instrument [Line Items]
Long-term debt	659,100,000	639,200,000
Fair Value | Unsecured Senior Notes | $500 million 3.750% - due January 15, 2026
Debt Instrument [Line Items]
Long-term debt	565,300,000	533,000,000
Fair Value | Unsecured Senior Notes | $400 million 5.375% - due November 30, 2043
Debt Instrument [Line Items]
Long-term debt	507,900,000	491,800,000
Fair Value | $1.5 billion floating rate credit facility expiring August 11, 2022
Debt Instrument [Line Items]
Line of credit facility, amount outstanding	$ 90,000,000	$ 0

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) - Letter of Credit $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Line of Credit Facility [Line Items]
Capacity on letters of credit	$ 11.3
Letters of credit, renewable term	1 year

Share Capital - Narrative (Deta

Share Capital - Narrative (Details) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)$ / shares	Sep. 30, 2020USD ($)$ / shares	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)contract$ / shares
Class of Stock [Line Items]
Preferred stock par value (in usd per share)		$ 0.2		$ 0.2
Liquidation preference per share (in usd per share)		$ 1,000		$ 1,000
Preferred shares lock-up period		5 years
Immediate payment applied from collateral already paid | $		$ 190.6	$ 0
Forward contract
Class of Stock [Line Items]
Number of forward contracts | contract				3
Strike price (in usd per share)	$ 12
Immediate payment applied from collateral already paid | $	$ 190.6
Net collateral paid balance | $		$ 39.7		$ 37.8
OppenheimerFunds
Class of Stock [Line Items]
Preferred stock par value (in usd per share)		$ 0.20
Liquidation preference per share (in usd per share)		$ 1,000
Preferred shares dividend rate (percent)		5.90%
Forward Contract, $200 Million, Entered On May 13th, 2019 | Forward contract
Class of Stock [Line Items]
Strike price (in usd per share)		$ 12		$ 20.51

Share Capital - Movements In Sh

Share Capital - Movements In Shares Issued And Outstanding (Details) - shares shares in Millions	Sep. 30, 2020	Dec. 31, 2019
Equity [Abstract]
Preferred shares issued (shares)	4	4
Preferred shares outstanding (shares)	4	4
Common shares issued (shares)	566.1	566.1
Less: Treasury shares for which dividend and voting rights do not apply (shares)	(106.8)	(112.8)
Common shares outstanding (shares)	459.3	453.3

Share Capital - Forward Contrac

Share Capital - Forward Contracts to Purchase Common Shares (Details) - Forward contract - USD ($) $ / shares in Units, shares in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Sep. 30, 2020	Dec. 31, 2019
Forward Contract Indexed to Issuer's Equity [Line Items]
Common shares purchased (shares)		25.8	25.8
Strike price (in usd per share)	$ 12
Value of total treasury shares recorded		$ 495,000,000	$ 495,000,000
Derivative liability		(308,700,000)	(496,500,000)
Forward Contract, $200 Million, Entered On May 13th, 2019
Forward Contract Indexed to Issuer's Equity [Line Items]
Notional value of futures contracts		$ 200,000,000	$ 200,000,000
Common shares purchased (shares)		9.8	9.8
Strike price (in usd per share)		$ 12	$ 20.51
Value of total treasury shares recorded		$ 198,700,000	$ 198,700,000
Derivative liability		(116,900,000)	(199,100,000)
Forward Contract, $200 Million, Entered On July 2nd, 2019
Forward Contract Indexed to Issuer's Equity [Line Items]
Notional value of futures contracts		$ 200,000,000	$ 200,000,000
Common shares purchased (shares)		10	10
Strike price (in usd per share)		$ 12	$ 20
Value of total treasury shares recorded		$ 193,700,000	$ 193,700,000
Derivative liability		(118,900,000)	(195,300,000)
Forward Contract, $100 Million, Entered On August 27th, 2019
Forward Contract Indexed to Issuer's Equity [Line Items]
Notional value of futures contracts		$ 100,000,000	$ 100,000,000
Common shares purchased (shares)		6	6
Strike price (in usd per share)		$ 12	$ 16.59
Value of total treasury shares recorded		$ 102,600,000	$ 102,600,000
Derivative liability		$ (72,900,000)	$ (102,100,000)

Other Comprehensive Income_(L_3

Other Comprehensive Income/(Loss) - Accumulated other comprehensive income (Details) £ in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020GBP (£)	Dec. 31, 2019USD ($)	Dec. 31, 2019GBP (£)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	$ 167.4	$ (133.4)	$ (61.4)	$ (71)
Other comprehensive income, net	0.7	0.5	0.8	1.7
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	13,967.7	14,299.7	14,318.3	8,936.2
Other comprehensive income/(loss)	168.1	(132.9)	(60.6)	(69.3)
Ending balance	14,350.6	13,961.6	14,350.6	13,961.6
Foreign currency transaction and translation gain (loss)	(5.8)	5.3	3.6	5.4
Foreign currency translation
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	167.4	(133.4)	(61.4)	(71)
Other comprehensive income, net	0	0	0	0
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(690.8)	(555.2)	(462)	(617.6)
Other comprehensive income/(loss)	167.4	(133.4)	(61.4)	(71)
Ending balance	(523.4)	(688.6)	(523.4)	(688.6)
Employee benefit plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0.7	0.5	0.9	1.3
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(125.9)	(116.9)	(126.1)	(117.7)
Other comprehensive income/(loss)	0.7	0.5	0.9	1.3
Ending balance	(125.2)	(116.4)	(125.2)	(116.4)
Equity method investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0	0	0	0.1
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0.1	0.1	0.1	0
Other comprehensive income/(loss)	0	0	0	0.1
Ending balance	0.1	0.1	0.1	0.1
Available-for-sale investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Currency translation differences on investments in foreign subsidiaries	0	0	0	0
Other comprehensive income, net	0	0	(0.1)	0.3
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	0.6	0.6	0.7	0.3
Other comprehensive income/(loss)	0	0	(0.1)	0.3
Ending balance	0.6	0.6	0.6	0.6
Accumulated Other Comprehensive Income/(Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(816)	(671.4)	(587.3)	(735)
Other comprehensive income/(loss)	168.1	(132.9)	(60.6)	(69.3)
Ending balance	(647.9)	$ (804.3)	(647.9)	$ (804.3)
Designated as Hedging Instrument
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Intercompany debt	$ 168.5		$ 168.5		£ 130	$ 172.1	£ 130

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Revenue, Major Customer [Line Items]
Total operating revenues	$ 1,497,600,000	$ 1,720,600,000	$ 4,515,500,000	$ 4,374,600,000
Deferred carried interest liabilities	58,000,000		58,000,000		$ 45,800,000	$ 61,300,000
Performance revenue recognized			0	6,800,000
Bermuda
Revenue, Major Customer [Line Items]
Total operating revenues	0	0	0	0
Americas
Revenue, Major Customer [Line Items]
Total operating revenues	1,118,200,000	1,286,000,000	3,356,200,000	3,037,500,000
UK
Revenue, Major Customer [Line Items]
Total operating revenues	148,600,000	191,400,000	465,300,000	611,900,000
EMEA ex UK (Europe, Middle East, and Africa)
Revenue, Major Customer [Line Items]
Total operating revenues	158,200,000	169,200,000	468,300,000	507,500,000
Asia
Revenue, Major Customer [Line Items]
Total operating revenues	$ 72,600,000	$ 74,000,000	$ 225,700,000	$ 217,700,000

Common Share-Based Compensati_3

Common Share-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common share-based compensation expense	$ 138.2	$ 158.8
Fair value of vested shares	$ 109.6	$ 161
Weighted average fair value of shares granted (usd per share)	$ 14.08	$ 14.47
Unrecognized compensation cost related to non-vested shares	$ 276
Weighted average non-vested shares compensation cost expected to recognize	2 years 4 months 28 days
Restricted stock awards | OppenheimerFunds
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock issued (shares)		6.2

Common Share-Based Compensati_4

Common Share-Based Compensation - Movements On Share Awards (Details) - $ / shares shares in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested at beginning of year Weighted Average Grant Date Fair Value (usd per share)	$ 21.94
Granted during period Weighted Average Grant Date Fair Value (usd per share)	14.08	$ 14.47
Forfeited during period Weighted Average Grant Date Fair Value (usd per share)	21.08
Vested and distributed during the period Weighted Average Grant Date Fair Value (usd per share)	24.54
Unvested at the end of the year Weighted Average Grant Date Fair Value (usd per share)	$ 19.42
Time- Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at the beginning of year (shares)	18.7	12.5
Granted during the year (shares)	8.1	15.4
Forfeited during the period (shares)	(0.3)	(0.5)
Vested and distributed during the year (shares)	(7.7)	(8.1)
Unvested at the end of the year (shares)	18.8	19.3
Performance- Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at the beginning of year (shares)	1.1	0.9
Granted during the year (shares)	0.9	0.6
Forfeited during the period (shares)	0	0
Vested and distributed during the year (shares)	(0.2)	(0.1)
Unvested at the end of the year (shares)	1.8	1.4

Operating Leases (Details)

Operating Leases (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)lease_renewal_option
Lessee, Lease, Description [Line Items]
Weighted-average remaining lease term	5 years 10 months 9 days
Number of lease renewal options (at least) | lease_renewal_option	1
Right-of-use asset	$ 307.4
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets
Lease liability	$ 335
Operating Lease, Liability, Statement of Financial Position [Extensible List]	us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
Weighted average discount rate for the operating leases (percent)	3.37%
Expected lease obligation for lease not yet commenced	$ 232.5
Expected lease term	15 years
Minimum
Lessee, Lease, Description [Line Items]
Renewal lease terms	1 year
Options to terminate leases within period	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease terms	10 years
Options to terminate leases within period	8 years 6 months

Operating Leases - Components o

Operating Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Operating lease cost	$ 23.2	$ 19.9	$ 65	$ 49.7
Variable lease cost	5.7	6.8	16.9	19.5
Less: sublease income	(0.5)	(0.2)	(1.5)	(0.4)
Total lease expense	28.4	26.5	80.4	68.8
Operating cash flows from operating leases included in the measurement of lease liabilities	23.9	20.9	69.3	54.1
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 6.8	$ 13.5	$ 35.1	$ 161.9

Operating Leases - Maturities o

Operating Leases - Maturities of Leases (Details) $ in Millions	Sep. 30, 2020USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2020 (excluding the nine months ended September 30, 2020)	$ 23.4
2021	78.9
2022	69.1
2023	55.9
2024	39.6
Thereafter	103
Total lease payments	369.9
Less: interest	(34.9)
Present value of lease liabilities	$ 335

Taxation - Reconciliation of Un

Taxation - Reconciliation of Unrecognized Tax Benefits (Details) $ in Millions	9 Months Ended
	Sep. 30, 2020USD ($)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at December 31, 2019	$ 69.9
Additions for tax positions related to the current year	2
Additions for tax positions related to prior years	0.9
Other reductions for tax positions related to prior years	(0.8)
Reductions for statute closings	(9.3)
Balance at September 30, 2020	$ 62.7

Taxation - Narrative (Details)

Taxation - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Income Tax Contingency [Line Items]
Unrecognized tax benefits	$ 62.7	$ 69.9
Reductions for statute closings	9.3
Unrecognized tax benefits that, if recognized, would affect the effective tax rate	48.8
Minimum
Income Tax Contingency [Line Items]
Range of possible change in gross unrecognized tax benefits	6
Maximum
Income Tax Contingency [Line Items]
Range of possible change in gross unrecognized tax benefits	$ 12

Earnings Per Common Share - Cal

Earnings Per Common Share - Calculation Of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share [Abstract]
Net income attributable to Invesco Ltd.	$ 191.7	$ 167.1	$ 313.7	$ 384.9
Weighted average shares outstanding - basic (in shares)	461.1	462.8	459	432.3
Dilutive effect of non-participating common share-based awards (in shares)	2.4	4.1	3	2.3
Weighted average shares outstanding - diluted (in shares)	463.5	466.9	462	434.6
Earnings per common share:
- basic (usd per share)	$ 0.42	$ 0.36	$ 0.68	$ 0.89
- diluted (usd per share)	$ 0.41	$ 0.36	$ 0.68	$ 0.89

Earnings Per Common Share - Nar

Earnings Per Common Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Performance- Vested
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	300,000	700,000	300,000	700,000
Time- Vested
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	0	0	0

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	3 Months Ended			9 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)	Jun. 30, 2020fund	Mar. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Loss Contingencies [Line Items]
Undrawn capital commitments				$ 385.1	$ 357
OppenheimerFunds
Loss Contingencies [Line Items]
Estimated liability recognized			$ 387.8
Liability adjustment			$ 380.5
Additional estimated liability recognized	$ 7.3			7.3
Seed Capital Subject to Massmutual Redemption Agreement
Loss Contingencies [Line Items]
Seed capital subject to redemption agreement	322.7			322.7
Rebalancing Correction Matter
Loss Contingencies [Line Items]
Number of funds affected in the rebalancing correction matter | fund		2
Payment to compensate for performance differences	$ 105.3			$ 105.3

Consolidated Investment Produ_3

Consolidated Investment Products (CIP) - Balances Related To CIP (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	$ 254	$ 652.2	$ 485.7
Accounts receivable and other assets of CIP	201.9	172.9
Investments of CIP	7,718.4	7,808
Less: Debt of CIP	(6,526.7)	(6,234.6)
Less: Other liabilities of CIP	(520.4)	(949.6)
Consolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	254	652.2
Accounts receivable and other assets of CIP	201.9	172.9
Investments of CIP	7,718.4	7,808
Less: Debt of CIP	(6,526.7)	(6,234.6)
Less: Other liabilities of CIP	(520.4)	(949.6)
Less: Retained earnings	0.1	9.5
Less: Accumulated other comprehensive income, net of tax	0	(9.4)
Less: Equity attributable to redeemable noncontrolling interests	(228.2)	(383.5)
Less: Equity attributable to nonredeemable noncontrolling interests	(415.9)	(454.9)
Invesco’s net interests in CIP	$ 483.2	$ 610.6

Consolidated Investment Produ_4

Consolidated Investment Products (CIP) - Condensed Consolidating Statement Of Income Line Items Reflecting Impact Of Consolidation Of Investment Products Into The Condensed Consolidated Statements Of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting, Other Significant Reconciling Items [Line Items]
Total operating expenses	$ 1,229.1	$ 1,445.5	$ 3,812.9	$ 3,881
Operating income	268.5	275.1	702.6	493.6
Equity in earnings of unconsolidated affiliates	18.6	19.8	46.7	46.9
Interest and dividend income	2.6	5.9	11.4	14.5
Other gains and losses, net	31.5	13.8	(15)	69
Other gains/(losses) of CIP, net	99.2	37	28.6	127
Income before income taxes	386.6	316.6	669.4	649.9
Net income	294.7	242.6	476.7	495.2
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(43.8)	(11.1)	14.6	(45.9)
Net income attributable to Invesco Ltd.	191.7	167.1	313.7	384.9
Consolidated
Segment Reporting, Other Significant Reconciling Items [Line Items]
Total operating revenues	(10.4)	(8.5)	(29.8)	(24.4)
Total operating expenses	4.4	9.4	22.9	17.6
Operating income	(14.8)	(17.9)	(52.7)	(42)
Equity in earnings of unconsolidated affiliates	(26)	(9.5)	10.8	(8.6)
Interest and dividend income	0	(0.7)	(0.3)	(3.1)
Other gains and losses, net	(5)	0.3	8.4	(28.7)
Interest and dividend income of CIP	76.3	90.4	241.2	261.8
Interest expense of CIP	(41.8)	(58)	(151.2)	(170.8)
Other gains/(losses) of CIP, net	64.7	4.6	(61.4)	36
Income before income taxes	53.4	9.2	(5.2)	44.6
Net income	53.4	9.2	(5.2)	44.6
Net (income)/loss attributable to noncontrolling interests in consolidated entities	(43.8)	(11.1)	14.6	(45.9)
Net income attributable to Invesco Ltd.	$ 9.6	$ (1.9)	$ 9.4	$ (1.3)

Consolidated Investment Produ_5

Consolidated Investment Products (CIP) - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)entity	Sep. 30, 2019USD ($)entity	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Dec. 31, 2018USD ($)
Variable Interest Entity [Line Items]
Number of entities no longer consolidated | entity			7	6
Number of deconsolidated voting right entities | entity			11	9
Pay interest at Libor or Euribor plus			10.00%
Collateral assets in default (percent)	1.03%	0.09%	1.03%	0.09%
Weighted average maturity (years)			10 years 3 months 10 days
Notes issued by collateralized loan obligations terms of arrangements interest rate margin spread low			0.40%
Notes issued by collateralized loan obligations terms of arrangements interest rate margin spread high			8.07%
Investments of CIP	$ 7,718,400,000		$ 7,718,400,000			$ 7,808,000,000
Bank loans
Variable Interest Entity [Line Items]
CLO Collateral Assets	6,596,800,000		6,596,800,000
Senior Secured Bank Loans And Bonds
Variable Interest Entity [Line Items]
Fair value, option, aggregate differences, long-term debt instruments	287,800,000		287,800,000			181,200,000
Significant Unobservable Inputs (Level 3)
Variable Interest Entity [Line Items]
Gains and losses included in the Condensed Consolidated Statements of Income	0	$ 300,000	10,800,000	$ 3,000,000
Real Estate Investments, Net	0	32,000,000	0	32,000,000	$ 0	78,600,000	$ 14,500,000	$ 11,800,000
Investments of CIP						78,600,000
De-consolidated
Variable Interest Entity [Line Items]
Carrying value and maximum risk of loss with respect to VIEs in which the Company is not primary beneficiary	164,900,000		164,900,000			188,000,000
Gain (loss) on deconsolidation			0	0
Investments of CIP	216,900,000	$ 626,100,000	$ 216,900,000	$ 626,100,000
Consolidated
Variable Interest Entity [Line Items]
Number of consolidated VIEs | entity			4	3
Number of consolidated voting right entities | entity			0	5
Investments of CIP	7,718,400,000		$ 7,718,400,000			7,808,000,000
Consolidated | Bank loans
Variable Interest Entity [Line Items]
CLO Collateral Assets	6,616,600,000		6,616,600,000			6,504,400,000
Consolidated | Significant Unobservable Inputs (Level 3)
Variable Interest Entity [Line Items]
Investments of CIP	0		0			78,600,000
Consolidated | Significant Unobservable Inputs (Level 3) | Bank loans
Variable Interest Entity [Line Items]
CLO Collateral Assets	$ 0		$ 0			$ 0

Consolidated Investment Produ_6

Consolidated Investment Products (CIP) - VIE Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	$ 254		$ 652.2	$ 485.7
Accounts receivable and other assets of CIP	201.9		172.9
Investments of CIP	7,718.4		7,808
Total assets	36,037.5		39,420.3
Debt of CIP	6,526.7		6,234.6
Other liabilities of CIP	520.4		949.6
Total liabilities	21,458.7		24,718.5
Total equity	14,350.6	$ 13,967.7	14,318.3	13,961.6	$ 14,299.7	$ 8,936.2
Total liabilities, temporary and permanent equity	36,037.5		$ 39,420.3
Newly consolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	9.1			9.9
Accounts receivable and other assets of CIP	1.2			3.1
Investments of CIP	114.2			401.9
Total assets	124.5			414.9
Debt of CIP	75.8			188.8
Other liabilities of CIP	37.8			226.1
Total liabilities	113.6			414.9
Total equity	10.9			0
Total liabilities, temporary and permanent equity	124.5			414.9
Deconsolidated VIEs
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	0.4			7.6
Accounts receivable and other assets of CIP	2.8			22.3
Investments of CIP	216.9			626.1
Total assets	220.1			656
Debt of CIP	0			526.2
Other liabilities of CIP	2			22.2
Total liabilities	2			548.4
Total equity	218.1			107.6
Total liabilities, temporary and permanent equity	220.1			656
Deconsolidated Voes's
Variable Interest Entity [Line Items]
Cash and cash equivalents of CIP	0.2			(0.2)
Accounts receivable and other assets of CIP	1.1			0.3
Investments of CIP	134.1			37
Total assets	135.4			37.1
Debt of CIP	0			0
Other liabilities of CIP	0			0
Total liabilities	0			0
Total equity	135.4			37.1
Total liabilities, temporary and permanent equity	$ 135.4			$ 37.1

Consolidated Investment Produ_7

Consolidated Investment Products (CIP) - Fair Value Hierarchy Levels Of Investments Held And Notes Issued By Consolidated Investment Products (Details) - USD ($) $ in Millions	Sep. 30, 2020	Dec. 31, 2019
Segment Reporting, Other Significant Reconciling Items [Line Items]
Total assets at fair value	$ 7,718.4	$ 7,808
Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Total assets at fair value		78.6
Bank loans
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	6,596.8
Consolidated
Segment Reporting, Other Significant Reconciling Items [Line Items]
Real estate investments		78.6
Total assets at fair value	7,718.4	7,808
Consolidated | Quoted Prices in Active Markets for Identical Assets (Level 1)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Real estate investments		0
Total assets at fair value	202.8	225.2
Consolidated | Significant Other Observable Inputs (Level 2)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Real estate investments		0
Total assets at fair value	7,273	7,290.8
Consolidated | Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Real estate investments		78.6
Total assets at fair value	0	78.6
Consolidated | Investments Measured at NAV as a practical expedient
Segment Reporting, Other Significant Reconciling Items [Line Items]
Real estate investments		0
Total assets at fair value	242.6	213.4
Consolidated | Bank loans
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	6,616.6	6,504.4
Consolidated | Bank loans | Quoted Prices in Active Markets for Identical Assets (Level 1)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Consolidated | Bank loans | Significant Other Observable Inputs (Level 2)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	6,616.6	6,504.4
Consolidated | Bank loans | Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Consolidated | Bank loans | Investments Measured at NAV as a practical expedient
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Consolidated | Bonds
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	550.3	705.9
Consolidated | Bonds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0.5
Consolidated | Bonds | Significant Other Observable Inputs (Level 2)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	550.3	705.4
Consolidated | Bonds | Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Consolidated | Bonds | Investments Measured at NAV as a practical expedient
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Consolidated | Equity securities, Equity and fixed income mutual funds
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	278	275.9
Equity and fixed income mutual funds, and investments in other private equity funds	23.3	29.8
Consolidated | Equity securities, Equity and fixed income mutual funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	202.4	204.4
Equity and fixed income mutual funds, and investments in other private equity funds	0.4	20.3
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Other Observable Inputs (Level 2)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	75.6	71.5
Equity and fixed income mutual funds, and investments in other private equity funds	22.9	9.5
Consolidated | Equity securities, Equity and fixed income mutual funds | Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Consolidated | Equity securities, Equity and fixed income mutual funds | Investments Measured at NAV as a practical expedient
Segment Reporting, Other Significant Reconciling Items [Line Items]
Bank loan, bonds and equity securities	0	0
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Consolidated | Investments in other private equity funds
Segment Reporting, Other Significant Reconciling Items [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	250.2	213.4
Consolidated | Investments in other private equity funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Consolidated | Investments in other private equity funds | Significant Other Observable Inputs (Level 2)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	7.6	0
Consolidated | Investments in other private equity funds | Significant Unobservable Inputs (Level 3)
Segment Reporting, Other Significant Reconciling Items [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	0	0
Consolidated | Investments in other private equity funds | Investments Measured at NAV as a practical expedient
Segment Reporting, Other Significant Reconciling Items [Line Items]
Equity and fixed income mutual funds, and investments in other private equity funds	$ 242.6	$ 213.4

Consolidated Investment Produ_8

Consolidated Investment Products (CIP) - Beginning And Ending Fair Value Measurements For Level 3 Assets And Liabilities (Details) - Significant Unobservable Inputs (Level 3) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance (Asset)	$ 0	$ 14,500,000	$ 78,600,000	$ 11,800,000
Purchases (Asset)	0	17,200,000	0	17,200,000
Sales (Asset)	0		0
Issuances (Asset)	0		0
Settlements (Asset)	0		0
Deconsolidation of CIP (Asset)	0		(89,400,000)
Gains and losses included in the Condensed Consolidated Statements of Income (Asset)	0	300,000	10,800,000	3,000,000
Ending balance (Asset)	$ 0	$ 32,000,000	$ 0	$ 32,000,000

Consolidated Investment Produ_9

Consolidated Investment Products (CIP) - Investments Measured at NAV as a practical expedient (Details) - Investments in other private equity funds - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Schedule of Investments [Line Items]
Fair Value	$ 242.6	$ 213.4
Total Unfunded Commitments	$ 118.2	$ 78.3
Weighted Average Remaining Term	6 years 9 months 18 days	6 years 8 months 12 days

Related Parties - Narrative (De

Related Parties - Narrative (Details) - Preferred Shares - OppenheimerFunds $ in Billions	9 Months Ended
	Sep. 30, 2020USD ($)
Related Party Transactions [Line Items]
Stock consideration	$ 4
MassMutual
Related Party Transactions [Line Items]
Approximate stake help in common stock of combined firm (percent)	16.50%

Related Parties (Details)

Related Parties (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Related Party Transactions [Line Items]
Total operating revenues	$ 1,497.6	$ 1,720.6	$ 4,515.5	$ 4,374.6
Cash and cash equivalents	1,066.6	1,048.6	1,066.6	1,048.6	$ 1,049
Unsettled fund receivables	317.5		317.5		162.7
Accounts receivable	662.1		662.1		855.6
Investments	769.8		769.8		829.5
Other assets	436.7		436.7		459.6
Total assets	36,037.5		36,037.5		39,420.3
Accrued compensation and benefits	714.9		714.9		1,030.7
Accounts payable and accrued expenses	1,810.8		1,810.8		1,904
Unsettled fund payables	304.3		304.3		154.2
Total liabilities	21,458.7		21,458.7		24,718.5
Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	1,372.5	1,583.5	4,132.8	3,968.1
Cash and cash equivalents	630.6		630.6		620.9
Unsettled fund receivables	266.1		266.1		113.6
Accounts receivable	435.4		435.4		599.8
Investments	601.9		601.9		633.5
Assets held for policyholders	7,882.2		7,882.2		10,835.3
Other assets	22.2		22.2		24.5
Total assets	9,838.4		9,838.4		12,827.6
Accrued compensation and benefits	22.7		22.7		65.7
Accounts payable and accrued expenses	80.8		80.8		53.8
Unsettled fund payables	273.1		273.1		116.6
Total liabilities	376.6		376.6		$ 236.1
Investment management fees
Related Party Transactions [Line Items]
Total operating revenues	1,096.8	1,257.1	3,302.2	3,252.1
Investment management fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	987.2	1,133.5	2,975.2	2,905.3
Service and distribution fees
Related Party Transactions [Line Items]
Total operating revenues	352.7	385.1	1,051.2	898.5
Service and distribution fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	338.9	375.6	1,004.8	864.1
Performance fees
Related Party Transactions [Line Items]
Total operating revenues	0	14.9	8.3	52.4
Performance fees | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	0	14.1	3.4	37.5
Other
Related Party Transactions [Line Items]
Total operating revenues	48.1	63.5	153.8	171.6
Other | Affiliated Entity
Related Party Transactions [Line Items]
Total operating revenues	$ 46.4	$ 60.3	$ 149.4	$ 161.2

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares	Oct. 27, 2020	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Subsequent Event [Line Items]
Common stock dividends declared per share (usd per share)		$ 0.155	$ 0.31	$ 0.62	$ 0.92
Preferred stock dividend declared (in usd per share)		$ 14.75	$ 16.06	$ 44.25	$ 16.06
Subsequent Event
Subsequent Event [Line Items]
Common stock dividends declared per share (usd per share)	$ 0.155
Preferred stock dividend declared (in usd per share)	$ 14.75